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Abstract 
Towards a R protein crystal structure 
Alba de San Eustaquio Campillo 
 
Resistance (R) proteins are a key component of plant innate immunity. R 
proteins are cytoplasmic immune receptors in plants that recognize specific 
microbe-associated molecular patterns (MAMPs). This recognition activates 
the second layer of the immune system in plants, called effector-triggered 
immunity (ETI).  
Most R proteins are multi-domain proteins with a C-terminal leucine-rich 
repeat (LRR) domain, a central nucleotide-binding (NB)-ARC domain and a 
variable N-terminal domain. The N-terminal domain can be a coiled-coil (CC) 
region or a homologue of the Drosophila Toll and mammalian Interleukin-1 
Receptors (TIR) structure. R proteins are members of the NB-ARC family of 
proteins, together with the human Apaf-1 and Caenorhabditis elegans CED-4, 
apoptosis receptors. The proposed activity of the NB-ARC domain is that of 
an ATPase. Studies conducted on R proteins have proved them to be 
ATPases. Nevertheless, a study with a subset of three R proteins showed 
their main activity was nucleotide phosphatases, not strict ATPases.  
In this project, expression, purification, and biochemistry experiments 
were conducted on Rx, R protein from potato that confers resistance against 
the potato virus X. Activity assays showed Rx-NBARC constructs to act as 
nucleotide phosphatases, not strict ATPases, supporting this newly found 
activity in R proteins. 	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1. Introduction
1.1 Introduction to plant immunity
Vertebrates have both innate and acquired immune systems to defend 
themselves  from  potential  infection.  Innate  immunity  has  developed  over 
evolution and recognizes unchanged structures on microorganisms (Blach-
Olszewska, 2005). Acquired or adaptive immunity is induced by infection, it  
recognizes and remembers specific pathogens and is able to mount stronger 
immune responses on pathogen reinfection (Alder et al., 2005). Plants posses 
only an innate immune system to activate a series of defence responses that 
will  arrest  pathogenic  microbes.  When a  pathogen  infects  a  non-resistant 
plant, disease might develop reducing the plant's fitness and even causing its 
death. The plants immune system recognizes the attack of organisms that 
cross physical  barriers including  the wax  layers  and rigid  cell  walls.  Plant 
pathogens that activate plant innate immunity include viruses, bacteria, fungi, 
oomycetes  and  nematodes  (Takken  and  Tameling,  2009).  The  immune 
responses they trigger protect the plant (Dangl and Jones, 2001, Zhang and 
Zhou, 2010, Zipfel, 2008). 
Plants do not have specialized mobile immune cells, as animals. All plant 
cells  have  the  innate  ability  to  recognize  and  respond  to  pathogens 
autonomously.  There  are  two  receptor  classes  involved  in  pathogen 
recognition.  The first  immune receptor  class is  represented by the pattern 
recognition receptors (PRRs) that are, mainly,  transmembrane receptors in 
the plasma membrane of the plant cell (Zipfel, 2008). PRRs detect pathogen- 
or microbe-associated molecular patterns (PAMPs or MAMPs, because non-
pathogenic organisms also possess PAMPs, Ausubel et al., 2005). They are 
responsible  for  the  inhibition  of  most  pathogens,  triggering  an  immune 
response that attenuates microbial growth and contributes to basal defence 
(Zhang and Zhou, 2010). Resistance or R proteins form the second layer of 
plant immunity. These are cytoplasmic immune receptors that detect, directly 
or indirectly, isolate-specific pathogen effectors, encoded by avirulence (avr) 
genes that are able to bypass PTI (Kim  et al., 2008). R proteins evolved to 
1
detect Avr effector proteins and trigger disease resistance.
Plants immunity evolution is described as a zigzag in Jones and Dangl, 
2006.  First,  PAMPs  are  recognized  by  PRRs,  causing  PTI.  Successful 
pathogens  synthesize  effectors  that  enhance  pathogenic  virulence  and 
overcome PTI, causing effector-triggered susceptibility (ETS). R proteins can 
specifically  recognize  these  effectors  and  activate  ETI  (effector-triggered 
immunity).  PTI  is  considered  a  basal  defence  response  while  ETI  is  an 
amplified reaction and, normally, induces a hypersensitive response (HR) at 
the infection site. HR is a rapid host cell suicide induced by pathogen infection 
detection by R proteins (Fig. 1; Heath, 2000).
PR
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Figure  1 Diagram of plant innate immune system. Based on Figure 3 from Pieterse  et al., 
2009.
Understanding the function of the components of plant innate immunity is 
of great relevance. It will provide important knowledge of possible methods for 
pest control. Identifying the proteins involved in plants immunity and how they 
function  will  permit  the  manipulation  of  those  proteins  towards  obtaining 
multiresistant crops (Baker et al., 1997).
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1.1.1 PAMP-triggered immunity (PTI)
Pattern  recognition  receptors  (PRRs)  recognize  specific  conserved 
epitopes in MAMPs at subnanomolar concentrations (Boller and He, 2009). 
These  are  essential  molecules  that  are  difficult  for  the  microorganism  to 
mutate  or  delete  without  negatively  affecting  the  fitness  of  the  microbe. 
Flagellin,  lipopolysaccharides,  bacterial  elongation  factor-Tu  (EF-Tu)  and 
peptidoglycans  are  examples  of  MAMPs/PAMPs  that  activate  a  PAMP-
triggered immunity or PTI (Jones and Dangl, 2006).
PRRs are  multidomain  transmembrane proteins  that  cross  the  plasma 
membrane only once (Zipfel, 2008). They present an extracellular leucine-rich 
repeat  (LRR)  region  outside  the  cell,  a  transmembrane  domain  and  an 
intracellular Ser/Thr protein kinase domain (Figure 2). There are at least 200 
LRR-kinases in the  Arabidopsis genome (Meyers  et al., 2003). An extra 56 
genes might be added if transmembrane proteins with LRR ectodomains but 
no intracellular kinases are included (Jones and Dangl, 2006). Most of the 
studies on PRRs have been conducted on the flagellin receptor FLS2 and EF-
Tu receptor EFR from Arabidopsis (Boller and Felix, 2009).
3
LRR 
N 
C 
S/T PK 
TM 
Figure  2 Diagram of a general PRR with leucine-rich repeats (LRR) at the N-terminus, a  
transmembrane (TM)  domain  and  a  C-terminus  serine/threonine  protein  kinase  (S/T  PK) 
domain.
Once MAMPs are recognized, the activation pathway or pathways of PTI 
converge  to  a  common response:  rapid  ion  fluxes  across  the  membrane, 
mitogen-activated kinase (MAPK)  signalling,  localized callose  deposition in 
the cell wall, accumulation of reactive oxygen species (ROS), and activation 
of  defence-related  genes  involving  WRKY  transcription  factors  after  the 
activation of MAPK pathways (Kim et al., 2008, Zhang and Zhou, 2010, Zipfel, 
2008). Although PTI prevents most infections, the disease resistance that it 
triggers can be suppressed by avirulence effectors encoded by avr genes in 
the pathogen (Boller and He, 2009, Pan  et al., 2000). R proteins recognize 
Avr effectors. Though mutations in R proteins do not affect PTI (Jones and 
Dangl, 2006), MAPK pathways are convergence points for both ETI and PTI 
(Kim et al., 2008). Tao et al., 2003 show that PTI overlaps R protein mediated 
immunity, but is temporally delayed and of lower amplitude. 
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1.1.2 Avr effector proteins
Some pathogens  express  avirulence  (avr)  genes,  whose  products  are 
called Avr proteins or effectors (Pan  et al., 2000). These effectors enhance 
the  pathogen’s  virulence  and,  many,  enable  it  to  overcome  PTI,  causing 
diseases in plants (Bent et al., 1994). Most Avr effectors are secreted by the 
pathogen through the type III secretion system (TTSS, Boller and He, 2009). 
The  C-terminal  domain  of  AvrPtoB  for  example,  a  Pseudomonas type  III 
effector,  initiates  degradation  of  PRRs,  inhibiting  PRR  signalling  and  PTI 
(Boller and He, 2009). 
1.1.3 Effector-triggered immunity (ETI)
Specific R proteins recognise specific Avr proteins in the so called gene-
for-gene recognition  model  (Staskawicz  et al.,  1995).  R proteins  in  plants 
have co-evolved with  these effectors to create a second layer  of immunity 
called  effector  triggered  immunity  or  ETI  (Jones  and  Dangl,  2006,  Zipfel,  
2008). ETI induces the production of ROS, modification of ion fluxes, protein 
phosphorylation,  reinforcement  of  the  cell  wall,  and  transcriptional 
reprogramming at the infection site and at close proximities (Belkhadir et al., 
2004,  Bent  et al.,  1994).  ETI  effects  are similar  to  those of  PTI,  but  they 
differentiate quantitatively and kinetically, ETI being faster and stronger (Shen 
et al., 2007). ETI immune responses normally lead to a host cell suicide at the 
invasion  site  known  as  the  hypersensitive  response  or  HR  (Shirasu  and 
Schulze-Lefert,  2000).  Nevertheless, disease resistance can happen in the 
absence  of  HR  (Heath,  2000, Jones  and  Dangl,  2006). This  has  been 
reported in potato, where Rx (R protein conferring resistance against potato 
virus  X)  does  not  cause  a  HR  while  activating  a  resistance  response 
(Bendahmane et al., 1999). This has also been shown in the case of Rsv-1 
(Hajimorad and Hill, 2001), which confers resistance against Soybean mosaic 
virus-N without inducing HR. 
The vast majority of R proteins are multi-domain proteins, so called NB-
LRR proteins, with  a central  nucleotide binding site (NB) and a C-terminal 
leucine rich repeat (LRR) region (Kim  et al., 2008). There are other smaller 
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groups of R proteins that lack a NB-LRR structure, but those are not going to 
be studied in this thesis. The NB domain of R proteins has similarity with that 
of  CED-4  (Caenorhabditis elegans)  and  Apaf-1  (human),  regulators  of 
apoptosis  (Bendahmane  et al.,  2002,  van  der  Biezen  and  Jones,  1998). 
Common sequences include the P-loop and other ATPase motifs  found in 
both eukaryotes and prokaryotes (Aravind  et al., 1999). NB-LRR R proteins 
can be divided into two subfamilies that differ in their N-terminus. They can 
present a coiled-coil (CC) motif (CC-NB-LRR proteins), or a TIR (homologue 
to the Drosophila Toll and mammalian Interleukin-1 Receptors) domain (TIR-
NB-LRR proteins) (Kim et al., 2008).
1.2 P-loop proteins, Apaf-1, and CED-4
The NB domain is, actually, a sub-domain that is part of a bigger domain,  
the NB-ARC domain. The NB-ARC domain is the most conserved region in R 
proteins (Lukasik-Shreepaathy et al., 2012). R proteins, together with Apaf-1 
(human  apoptotic  protease-activating  factor  1)  and  CED-4  (apoptosis 
regulator  from  Caenorhabditis  elegans),  form  the  NB-ARC  protein  family, 
which is member of the P-loop NTPases superfamily (Figure 3, van Ooijen et 
al., 2008). P-loop NTPase conserved domains are present in 5-10% of the 
predicted gene products of sequenced prokaryotic and eukaryotic genomes. 
This makes P-loop NTPases the most common NTP-binding proteins in the 
proteome  (Gueguen-Chaigon  et al.,  2007).  P-loop  containing  proteins  are 
involved in various cellular processes including signalling, metabolism, and 
regulation  (Gueguen-Chaigon  et al.,  2007).  The  most  common  reaction 
catalysed by this domain is the hydrolysis of the  β-γ  phosphate bond of a 
bound  nucleotide  triphosphate  to  generate  the  diphosphate  (Leipe  et al., 
2004).
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CARD NB-ARC 
CC/TIR 
Apaf-1 
CED-4 
R protein 
WD40Rs 
LRRs 
CARD NB-ARC 
NB-ARC 
Figure 3 Diagram of Apaf-1, CED-4 and a general R proteins. They all share a central NB-
ARC domain. Apaf-1 and CED-4 have a N-terminus CARD domain, while most R proteins 
have a CC/TIR domain. Apaf-1 presents C-terminal WD 40 repeats, while R proteins have 
leucine-rich repeats. 
Both Apaf-1 and CED-4 have been crystallized and their structures solved 
(Riedl et al., 2005, Qi et al., 2010). Comparison of their sequence with that of 
resistance proteins allows a better understanding of R proteins structure and 
function as they share sequence similarities (Takken and Goverse, 2012).
Apaf-1, in the presence of  cytochrome  c and ATP/dATP, undergoes a 
conformational change and forms the apoptosome, recruiting caspases and 
activating programmed cell death (Riedl et al., 2005). Four sub-domains can 
be  identified  in  the  NB-ARC  domain  of  Apaf-1  (Riedl  et al.,  2005):  a 
nucleotide-binding  sub-domain and three ARC sub-domains  (ARC1, ARC2 
and ARC3). The NB sub-domain is a classical NTPase fold and, therefore, is 
part of the P-loop NTPase superfamily (Takken et al., 2006). The structure of 
the P-loop is  that  of  a  three layered  α/β sandwich  with  central  parallel  β-
sheets surrounded by α-helices at both sides (Leipe et al., 2004). There are 
two distinct motifs in the sequence of the P-loop: Walker A (or kinase 1a) and 
Walker B (or kinase 2 motif) (Gueguen-Chaigon  et al., 2007, Takken  et al., 
2006). These motifs bind the  β and  γ  phosphates of the bound NTP and a 
Mg+2 cation respectively  (Leipe  et al.,  2004).  ARC1 is  a four-helix  bundle, 
ARC2 a winged-helix fold, and ARC3 is another helical bundle (Leipe  et al., 
2004, Riedl  et al.,  2005,  Yan  et al.,  2005).  The  nucleotide  binds  at  the 
interface between the NB, ARC1, and ARC2 sub-domains. Depending on the 
nucleotide that is bound to the NB domain, ATP or ADP, the conformation 
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adopted  by  Apaf-1  undergoes  a  change.  Thus  Apaf-1  perfectly  suited  to 
activate signalling pathways through conformational  change (Takken  et al., 
2006). The ADP molecule is buried between the NB sub-domain and the three 
ARC sub-domains, maintaining the protein in its inactive conformation (Riedl 
et al., 2005). 
In  the  case  of  CED-4,  its  inactive  conformation  corresponds  to  an 
asymmetric homodimer sequestered by CED-9 (anti-death protein) and with a 
molecule of ATP buried and bound at the NB domain (Yan et al., 2005). Upon 
activation, CED-4 is liberated from CED-9 and forms a tetramer of asymmetric 
dimers (Qi  et al., 2010), the apoptosome. This homooligomer interacts with 
two  CED-3 (a  caspase)  molecules,  activating  programmed cell  death in  a 
similar  manner  to  that  of  Apaf-1.  CED-4,  as  Apaf-1,  when  forming  the 
apoptosome, is bound to an ATP molecule and a Mg+2 cation (Qi et al., 2010), 
which are deeply buried. Nevertheless, no H2O molecule is found in the NB-
ARC domain of CED-4, its catalytic site, so it is doubtful that it hydrolysis ATP. 
CED-4 might function by nucleotide exchange and not as an ATPase. CED-4 
molecules  present  an  NB  sub-domain,  ARC1  and  ARC2  sub-domains. 
However, the ARC3 sub-domain found in Apaf-1 is missing in this NB-ARC 
protein and is substituted by a short linker of unknown structure (Qi  et al., 
2010, Yan et al., 2005). R proteins posses an NB sub-domain, an ARC1 sub-
domain and an ARC2 sub-domain, but lack ARC3, as CED-4 (Qi et al., 2010). 
1.3 R proteins
R proteins are intracellular innate immune receptors that trigger ETI. Most 
of  them have  a  central  nucleotide-binding  (NB)  domain  and  a  C-terminus 
leucine-rich (LRR) region of 20-30 amino acids (Figure 4, van Ooijen  et al., 
2008).  The majority of these NB-LRR proteins have a conserved N-terminus 
with  a  TIR  (Toll/Interleukin-1  Receptor)  domain.  Other  NB-LRR  proteins 
exhibit a coiled-coil (CC) region in the N-terminus. These two NB-LRR protein 
groups are called TNL and CNL respectively (Meyers  et al., 1999). The are 
other  NB-LRR proteins  that  do  not  have  a  conserved  N-terminus  domain 
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(Dodds and Rathjen, 2010). R proteins are thought to function as molecular 
switches (Takken and Tameling, 2009) where their conformation varies with 
the nucleotide bound to the NB domain. 
Figure 4 Diagram of R proteins classification. Most R proteins can be divided into two sub-
groups: CNL and TNL proteins. They have a central NB-ARC domain and N-terminal LRRs. 
They  differentiate  in  the  C-terminus:  CNLs  have  a  CC  region  while  TNLs  have  a  TIR 
structure.  There  are  some  other  R  proteins  that  do  not  have  a  conserved  C-terminus, 
although they do have a conserved NB-LRR structure.
1.3.1 R proteins genes and their evolution
R gene (dominant or semidominant alleles) products specifically identify 
pathogen avirulence gene products in a gene-for-gene recognition manner 
(Pan et al., 2000). Modelling suggests that indirect recognition can lead to a 
stable, durable resistance, while direct recognition can, most likely,  lead to 
relatively rapid evolution of new virulence phenotypes in the pathogen and 
resistance in the plant (Dodds et al., 2006). Examples of indirect Avr receptors 
in Arabidopsis are Rpm1, Rps2 and Rps5. The corresponding loci of these R 
proteins  show  low  levels  of  genetic  diversity.  An  evolutionary  arms  race 
occurs in direct R-Avr protein recognition, as happens with L, an R protein 
from flux, and AvrL567, from Melampsora lini (Dodds et al., 2006).
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Most R genes have evolved by gene duplication followed by diversifying 
selection (Dodds et al., 2006, Pan et al., 2000). Unequal crossing-over is the 
most common mechanism of gene duplication observed for the production of 
R gene homologues. It has been demonstrated in a number of R loci including 
the Rp1 locus of maize (Bent, 1996) and the L locus of flux (Ellis et al., 1999). 
Alternative splicing and interallelic recombination has also been demonstrated 
(Michelmore and Meyers, 1998, Pan et al., 2000, Staskawicz et al., 1995). 
Variation of  R gene sequences is  concentrated over  predicted binding 
surfaces  within  the  LRR  region  (Allen  et al.,  2004,  Dodds  et al.,  2006, 
Michelmore and Meyers, 1998, Seeholzer  et al.,  2010 ). Both the NB-ARC 
domain and the N-terminus of R proteins are highly conserved (Allen  et al., 
2004), suggesting the conservation of their function. 
Different plant species have various numbers of R genes. The Columbia 
(Col0)  ecotype  of  Arabidopsis has  149  genes  that  encode  for  NB-LRR 
proteins. This number increases to ~200 if  the genes coding for truncated 
versions of R proteins are added (Meyers  et al., 2003). In rice, this number 
goes up to more than 600 NB-LRR genes (Bai  et al., 2002). Some genome 
sequencing studies (Bai et al., 2002, Meyers et al., 1999, Meyers et al., 2003) 
have demonstrated that the majority of NB-LRR protein encoding genes are 
arranged in clusters, both in Arabidopsis and rice (Meyers et al., 2003). This 
supports the hypothesis of generating novel resistance specificities through 
recombination. There are differences in R genes, depending on the type of 
NB-LRR R proteins they encode. It has been shown in  Arabidopsis (Meyers 
et al., 2003) that its CNL proteins are generally encoded by single exons with  
the exception of two subclasses, which present introns in unique positions. On 
the other hand, TNL proteins are encoded by modular exons where protein 
domains  are  separated  by  introns  in  a  conserved  manner  (Meyers  et al., 
2003).
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1.3.2 R protein structure-function
Most  plant  R  proteins  are  formed  by  a  central  NB  domain  and  a  C-
terminal LRR (Shen  et al.,  2007). The N-terminus can be formed by a CC 
structure, a TIR domain or not have a conserved N-terminus domain (Dodds 
and Rathjen, 2010, Goff  et al., 2002, Meyers  et al., 1999, Pan  et al., 2000, 
Shen et al., 2007). These NB-LRR R proteins are subject to a more  detailed 
description below.
R protein C-terminus
The C-terminus of R proteins presents a series of leucine-rich repeats. 
The repeated motif  comprises  ~24 amino acids  where  leucines and other 
hydrophobic  residues  are  found  at  regular  intervals  (Figure  5,  Kobe  and 
Deisenhofer,  1995).  LRR  domains  are  found  in  many  other  proteins  and 
normally function as protein-protein interaction regions or as peptide-ligand 
binding sites (Bai  et al., 2002). The LRR domain in plant R proteins can be 
involved in the recognition of ligands produced by the activity of Avr effectors 
or  it  may provide  the  platform for  the  interaction  of  R proteins  with  other 
proteins involved in the recognition of these effectors (Bent, 1996).
11
Figure  5 Structure of ribonuclease inhibitor (Kobe and Deisenhofer,  1995).  Generated by 
Pymol (pdb = 2BNH). 
The crystal  structure  of  porcine  RNase  inhibitor  (protein  with  an  LRR 
region) was solved in Kobe and Deisenhofer, 1995. Its tertiary structure was 
that of a fist with each of the curled fingers representing a single LRR. It is  
likely that  exposed amino acids are the ones presenting specificity for  the 
ligand  (Avr  effector  or  partner  protein),  while  the  conserved  hydrophobic 
amino acids are oriented internally and have a structural role (Bent, 1996). 
Modelling  of  the  LRR  domain  of  Lr10,  a  R  protein  from  wheat,  shows 
similarities in its structure with that of the RNase inhibitor (Sela et al., 2012). 
The  region  is  divided  into  N-  and  C-terminal  parts.  The  N-terminal  part 
contains a high number of positively charged residues and might be involved 
in  the modulation of  NB-ARC domain  activation,  while  the  C-terminal  part 
accumulates aromatic residues and might have a role in the interaction with 
upstream  activators  as  Avr  effectors  or  other  proteins  involved  in  the 
recognition of those effectors (Belkhadir et la., 2004). 
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R protein NB domain
The central domain of R proteins is identified as a nucleotide binding site 
(NB). This NB sub-domain is part of a bigger domain called NB-ARC. It  is 
formed by three sub-domains: NB, ARC1 and ARC2 (van Ooijen et al., 2008). 
These sub-domains are highly conserved in various eukaryotic proteins where 
they form a  nucleotide-binding  pocket  required  for  ATP-  and  GTP-binding 
(Bent, 1996, Meyers et al., 1999, Traut, 1994).
The conserved NB domain is formed by five parallel β sheets with seven 
α-helices surrounding it,  ARC1 is  formed by a bundle of  four  helices and 
ARC2 forms a winged-helix (Takken and Goverse, 2012). To date, no crystal 
structure of a R protein NB-ARC domain has been obtained. Models  created 
using crystal structures of related proteins, as Apaf-1 and CED-4, show the 
NB-ARC domain as a compact globular structure (Riedl et al., 2005, Takken 
and Goverse, 2012, Yan et al., 2005). 
Studies  with  Rx  show that  ARC1  is  necessary  for  the  intramolecular 
interaction between the N-terminus and the LRR domain (Rairdan and Moffet, 
2006). Mutations in the LRR domain support the hypothesis of the interaction 
between  LRR and  NB-ARC domains  being  due  to  various  contact  points 
(Rairdan and Moffet, 2006). This would explain how the interaction between 
these domains is maintained despite the high degree of variability seen in NB-
LRR proteins. ARC2 contains a MHDV motif. In Bendahmane et al., 2002 and 
de la Fuente van Bentem et al., 2005 mutations of the conserved Asp in this 
motif are studied and shown to cause a constitutive gain-of-function where the 
R  protein  cannot  be  autoinhibited.  Rairdan  and  Moffet,  2006  propose  it 
communicates the recognition of an effector, eliciting the activation of the NB-
ARC protein. 
R proteins N-terminus
Plants NB-LRR R proteins are divide into two subgroups depending on 
the domain present in their N-terminus. This could be a homologue of the TIR 
domain or a CC structure (Bent, 1996).
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-Toll/Interleukin-1 Receptor (TIR) domain
Examples  of  TNL R proteins  are  N,  from tobacco,  L6,  from flax,  and 
RPP5,  from  Arabidopsis (Bent,  1996).  The crystal  structure  of  L6TIR was 
solved in Bernoux et al., 2011. It shows that L6TIR forms an asymmetric unit 
with two monomers. This domain is necessary and sufficient for the activation 
of HR. Mutations at the interface do not permit dimerization, and correspond 
with a loss-of-function in planta, suggesting a correlation between these two 
events (Bernoux  et al., 2011). In Chan et al., 2010 AtTIR (TIR domain from 
Arabidopsis  thaliana),  was  crystallized  and  it's  structure  studied.  This 
molecule  is  a  monomer  in  solution,  but  shows  dimer  interfaces  in  the 
crystallographic cell. This crystal structure revealed the existence of an  αD-
helix, which is present in all  TIR plant proteins, but absent in bacteria and 
mammalian TIR domains (Chan et al., 2010). Mutations in this area in other R 
proteins have been shown an impact on function, suggesting a dual role of  
TIR  domains  in  R  proteins:  transmission  of  the  resistance  signal  and  the 
death signal through protein-protein interactions (Chan et al., 2010, Weaver 
et al., 2006). 
-Coiled-coil (CC) structure
The crystal  structure of  MLA10CC, a CNL R protein  from barley,  was 
recently  solved  (Maekawa  et al.,  2011).  It  shows  that  CC structures  form 
homodimers. This data supports structural models for RPM1, a CNL R protein 
from Arabidopsis (Takken and Goverse, 2012).
It has been demonstrated (Hwang et al., 2000) for Mi-1, a CNL R protein 
from tomato that confers resistance against root-knot nematodes, that the N-
terminus represses the ability of the LRR region to transmit the signal for ETI 
activation. In the presence of the nematode, an Avr effector produced by the 
nematode  interacts  directly  or  indirectly  with  the  N-terminus  or  the  LRR 
region, preventing repression of cell death. 
An EDVID conserved motif  is found in the CC domain (Rairdan  et al., 
2008). This motif appears to be involved in the intramolecular NB-ARC-LRR-
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CC  interaction.  Mutations  in  NB-ARC-LRR  inhibit  the  interaction  of  these 
domains with the CC, suggesting that a correct tertiary structure is needed for 
the correct intramolecular interactions to take place (Rairdan et al., 2008).
1.3.3 Effectors recognition and cell compartmentalization
Pathogen  effectors  are  detected  specifically  by  R  proteins.  This 
interaction can be direct or indirect (Kim et al., 2008). The interaction between 
the AvrM effector from flax rust and the M R protein,  a TNL R protein,  is  
studied in Catanzariti  et al.,  2010. This is an example of direct  interaction 
between a R protein and its effector. M recognises AvrM via its LRR. This is 
necessary and sufficient to elicit HR (Catanzariti et al., 2010). In other studies, 
indirect  effector-R protein relations are studied (Bhattacharjee  et al.,  2011, 
Dodds,  2010).  Pathogen  effectors  from  Peronospora,  Erysiphe, and 
Pseudomonas interact with Arabidopsis EDS1 or RIN4. These proteins form a 
guard complex with TNL and CNL R proteins respectively. EDS1 is essential 
for ETI to happen with all  TNL R proteins studied to date (Wiermer  et al., 
2005).  The recognition of the correct effector by EDS1 or RIN4 causes the 
activation of the R protein and starts ETI (Bhattacharjee et al., 2011). Heidrich 
et al., 2011 and Wirthmueller et al., 2007 demonstrate that Arabidopsis EDS1 
interacts with the  P. syringae Avr effector AvrRsp4 and the R protein RSP4 
(TNL R protein). For a fully activated immune response, the three molecules 
have to be localized in the nucleus (Heidrich et al., 2011 and Wirthmueller et 
al.,  2007). It  is likely that a nuclear mobilizing signal is produced once the 
interaction with the effector takes place. 
R proteins have also been proposed to work in a “bait and switch” model 
(Collier  and  Moffet,  2009).  This  model  unites  the  direct  and  indirect 
recognition  of  pathogen effectors.  The presence of  other  host  proteins  as 
decoys  does  not  inhibit  the  possibility  of  a  direct  interaction  between  the 
effector and the R protein. The “bait and switch” model proposes a two-step 
recognition  process  where  the  effector  interacts  with  the  LRR  R  protein 
domain and with  other proteins that act as cofactors.  Once the effector is 
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recognized, the NB site is hypothesized activate a single or reduced number 
of signalling pathways resulting in the activation of ETI. 
1.3.4 Current activation model of R proteins
Activation of R proteins triggers a localized cell death known as the HR 
(Monaghan  and  Li,  2008).  R protein  activation  should  therefore  be  tightly 
regulated. When HR occurs, pathogens are confined in dead cells with no 
nutrients. This is usually sufficient to prevent the spread of the infection in the 
plant. 
In  order  to  avoid  inappropriate  activation,  intramolecular  interactions 
between the multiple domains autoinhibit  the protein (Takken  et al.,  2006, 
Takken and Tameling, 2009). The current hypothesis for how R proteins are 
activated is that of an “on-off” switch (Figure 6). The “off” or resting state is 
represented by an ADP molecule bound to the NB-ARC domain in absence of 
pathogens (Monaghan and Li, 2008). ADP interacts with the NB-ARC domain, 
maintaining the protein in a very stable conformation. In addition, both the N-
terminal  and LRR domains  interact  with  the  NB-ARC domain  (Ade  et al., 
2007).
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Figure 6 A Diagram of a general R protein. B Diagram of the "on-off" switch activation model 
for R proteins.
Effector recognition is hypothesized to cause a conformational change in 
the protein where the N-terminal part of the LRR domain stops interacting with  
the NB-ARC domain enabling the exchange of ADP for ATP and eliciting the 
protein  to  enter  its  “on”  or  activated  state  (Ade  et al.,  2007,  Lukasik  and 
Takken,  2009).  Nucleotide  exchange  causes  an  additional  conformational 
change that stops the C-terminal domain from interacting with the NB-ARC-
LRR domains (Lukasik and Takken, 2009). This permits the establishment of  
interactions  between  the  R  protein  and  other  proteins  involved  in  the 
signalling  process,  mainly  through the N-terminus (Ade  et al.,  2007).  ATP 
hydrolysis  returns the protein  to  its  “off”  state,  forming ADP. This  ATPase 
activity of R proteins has been demonstrated by the identification of loss-of-
function mutations (Tameling  et al.,  2002) in the NB-ARC domain of I-2, a 
resistance protein  from tomato  where  ATPase defective  mutants  are  non-
functional in planta. This data supports the hypothesis that R proteins work as 
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strict ATPases in a switch activation model. 
This  model  is  further  consistent  with  data  from  nucleotide  binding, 
oligomerization (NOD)-like receptors, intracellular animal immune receptors, 
which are also members of the P-loop family of proteins (Austin et al., 2002). 
Various gain-of-function mutations have been studied on Nod2 (Danot et al., 
2009, Rairdan and Moffett, 2006). These mutations abolish the capability of 
the NB domain in Nod2 to hydrolyse ATP, forcing the protein to remain in a 
constitutively activated state.
Though there is not much information about the downstream molecular 
events that occur after effector recognition, stable R protein complexes are 
formed. These complexes involve different co-chaperones like HSP90, RAR1, 
Suppressor  of  G2  allele  of  SKP1  (SGT1),  heat  shock  cognate  70  kDa 
(HSC70) and protein phosphatase 5 or PP5 (Monaghan and Li, 2008). The 
role  of  co-chaperones  may  be  that  of  stabilizing  activated  R  proteins  or 
modifying  them.  Experiments  where  some  of  these  co-chaperones  were 
suppressed  show that  they are  necessary  for  HR activation  (Lukasik  and 
Takken,  2009).  Transcriptional  factors  and nucleo-cytoplasmic  transporters 
have been identified to  bind to the N-terminal  part  of  NB-ARC proteins in 
plants (Lukasik and Takken, 2009).
A study in Arabidopsis (Aarts et al., 1998) showed that some R proteins 
signal through the EDS1 (enhanced disease susceptibility) lipase-like protein 
(RPP2,  RPP4,  RPP5,  RPP21 and RPS4),  while  RPS2 and  RPS5 require 
NDR1 (nonrace-specific disease resistance).  This study also demonstrated 
that RPM1 and RPP8 do not depend on any of these molecules to activate 
their immune responses in  Arabidopsis. It  is thought that the preference of 
one pathway or the other is dependent on the R protein structure rather than 
the  pathogen  type.  Some  studies  have  shown  that  activated  NB-LRR  R 
proteins  (MLA10  in  barley,  N  in  tobacco  and  RPS4  in  Arabidopsis) 
accumulate in the nucleus where they might derepress inhibitory transcription 
factors to activate defence gene expression (Shen et al., 2007). The truth is 
that  the pathway or  pathways  leading R proteins to  activate  host  defence 
against pathogen invasion are not yet known.
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1.4 The biochemistry of the NB domain
The accepted hypothesis for R proteins activation model supports them 
as strict ATPases (Tameling et al., 2006). However, recent evidence found by 
Fenyk  et al., 2012 demonstrated this biochemistry is not true for a series of 
NB-LRR proteins. NB domains of R1 (an orphan R protein from rice), Rpm1 
(R protein  from  A.  thaliana), and PSiP (an  orphan R protein  from maize) 
proved  to  have  a  nucleotide  phosphatase  activity.  R1  was  used  to  fully 
characterize this protein’s biochemistry. Terminal phosphates are sequentially 
cleaved  leading  to  the  formation  of  adenosine  as  the  final  product  when 
adenosine nucleotides are used as substrate. This is in contrast to previous 
work with other R proteins (I-2 and Mi-1) that showed they act as ATPases 
(Tameling  et al.,  2002).  R  proteins  NB  domains  might  therefore  exhibit 
different enzyme activities.  
1.5 Recombinant R proteins
R proteins have been studied  in planta in many cases. Some examples 
are Azevedo et al., 2006, Baures et al., 2008, Goulden and Baulcombe, 1993 
and Kohm et al., 1993. However, R proteins expression and purification from 
plant cultures has proved to be challenging. Examples of active protein in the 
literature are scarce, but promising. 
Tameling et al., 2002, refolded the CC-NB-ARC portion of I-2 and Mi-1 in  
vitro, after  purification  from  inclusion  bodies.  The  results  demonstrated 
samples of active protein that show ATPase activity. 
Ueda et al., 2006, expressed a number of constructs of the N R protein 
from tobacco in  E. coli. This recombinant proteins had a GST tag attached 
that was used for its purification on a Glutathione Sepharose™ column. N was 
characterized as an ATPase, similar to I-2 and Mi-1. 
Schmidt  et al., 2007 expressed M (flax-rust R protein) in  Pichia pastoris 
with a N-terminal 9x histidine tag and a deletion of the first 21 amino acids. No 
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biochemical experiments were performed. 
Bernoux et al., 2011 determined the crystal structure of L6 (R protein from 
Linum usitatissimum)  TIR domain  (amino acids  29-229),  demonstrating  its 
importance in immune signalling. The recombinant protein was expressed in 
E. coli BL21(DE3) cells. 
Maekawa et al., 2011 successfully expressed (in E. coli) and crystallised 
the CC domain of MLA (R protein from barley).  Full  length MLA was also 
expressed and purified from insect cells and its nucleotide binding properties 
were tested. Their data show that MLA forms relatively stable complexes with 
ADP, but not with ATP. 
Ve  et al., 2011 accomplished structure studies from crystals of the TIR 
domain of L6 (amino acids 29-229, as Bernoux et al., 2011), after expression 
in  E.  coli cells  and  purification  with  a  hexa-histidine  tag,  which  was 
subsequently removed.  
Williams et al., 2011 performed a series of biochemical experiments with 
various mutant versions of M, which sustain the switch activation model of R 
proteins.  Correct  functioning  of  resistance  signalling  would  involve  the 
exchange of ADP for ATP as the “off” state of R proteins would correspond to 
the protein bound to an ADP molecule. 
In  Fenyk  et al.,  2012,  NB  domains  from  R1,  Rpm1,  and  PSiP  were 
expressed from  E. coli cultures and purified with Strep-Tactin Superflow to 
obtain a solution of native active protein. In this case, all proteins showed a 
nucleotide phosphatase enzyme activity in vitro. 
In  light  of  the  contrasting  biochemistry  in  different  R  proteins,  further 
studies should be conducted in order to fully characterize their activity.
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1.6 Aims
Fenyk  et al.,  2012 reported a new activity in a group of three NB-LRR 
proteins.  R1,  Rpm1  and  PSiP  were  demonstrated  to  act  as  nucleotide 
phosphatases, catalysing the production of nucleosides from nucleotides with 
a preference for the nucleotide monophosphate as substrate. This differs from 
the,  to  date,  accepted  hypothesis  of  R  proteins  acting  as  strict  ATPases 
(Tameling et al., 2002). The nucleotide phosphatase activity is intrinsic to the 
NB sub-domain,  although  the  role  of  the  ARC sub-domain  cannot  yet  be 
defined. This biochemistry means that the protein continues hydrolysing the 
nucleotide  until  producing  a  nucleoside,  instead  of  stopping  at  the 
diphosphate nucleotide. 
A computed structural model for the NB domain of R1 was used to predict 
important catalytic residues and the effect of mutating them in the protein’s 
activity.  (Fenyk  et al.,  2012).  There  are  no  R  proteins  NB-ARC  domain 
crystals in the literature. Only human Apaf-1 (Riedl  et al., 2005) and CED-4 
(Qi  et al.,  2010) have been crystallized and their  structures solved.  These 
structures revealed the importance of the locality of the nucleotide bound to 
the NB-ARC domain. The conformation of Apaf-1 and CED-4 is dependent on 
the  bound  nucleotide.  This  data  has  been  used  to  create  models  for  R 
proteins as they share similarities and are members of the NB-ARC family of 
proteins (Takken and Goverse, 2012). Nevertheless, the information obtained 
from a model is not comparable to that collected from a crystal structure. 
Crystallizing the active  domain of  a  R protein  is  essential  for  the fully 
understanding  of  the  role  of  R  proteins  in  plant  innate  immunity.  This 
knowledge would assist in the identification of important residues, which are 
key for the proteins activity and specificity.  These residues might be used, 
after their identification, as targets for R protein modification. Multiresistant R 
proteins might be introduced into crop strains. This would reduce costs of crop 
protection  and  minimize  the  use  of  chemical  pesticides,  reducing 
environmental contamination. 
The data presented below shows the first steps of a bigger project that 
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can be followed towards achieving a R protein crystal structure. Expression 
and purification of a R protein that can be used for biochemical experiments 
are the aims of this project. Improvement of the techniques developed here 
may render a way towards the obtaining samples of R protein that can be 
used for crystallography trials. 
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2. Materials and Methods
2.1 Most commonly used buffers
2x TBST buffer (see 2.4.5):
50 mM Tris-HCl pH 8.0
30 mM NaCl
0.2 % (v/v) Tween 20
5x STOP buffer (see 2.5.6):
100 mM Tris-HCl, pH 8.0
2.5 % SDS
100 mM EDTA
10 units µL-1 proteinase K
ADPase assay developing buffer (see 2.5.4):
9:1 isopropanol: 33 % (v/v) aqueous ammonia
ATPase assay developing buffer (see 2.5.3):
15.5 % (v/v) 33 % (v/v) aqueous ammonia
15.5 % (v/v) isobutyl-alcohol
10.5 % (v/v) isobutyl-ethanol
31.5 % (v/v) 2-etoxyethanol
Bacterial wash buffer (see 2.4.1):
50 mM Tris-HCl pH 8.5
1mM EDTA
Binding buffer (see 2.3.6):
6 M Sodium Perchlorate
50 mM Tris-HCl pH 8.0
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10 mM EDTA
Blocking buffer (see 2.4.5):
2x TBST buffer
1.5 % (w/v) BSA
5 % (w/v) milk powder
Dialysis buffer (see 2.4.13):
50 mM Tris-HCl pH 8.0
15 mM NaCl
Glutathione Sepharose buffers (see 2.4.8):
Wash buffer: 50 mM Tris-HCl pH 8.0
200 mM NaCl
Elution buffer: 50 mM Tris-HCl pH 8.0
10 M reduced glutathione
Inclusion bodies purification (see 2.3.9 and 2.4.10):
Wash buffer: 50 mM Tris-HCl pH 8.0
4 M urea
500 mM NaCl
1 mM EDTA
1 mg / mL deoxycholate
Solubilisation buffer: 50 mM Tris-HCl pH 8.0
4 M urea
10 mM DTT
Ligation buffer (see 2.3.7):
60 mM Tris-HCl pH 7.8
20 mM MgCl2
20 mM DTT
2 mM ATP
10 % (w/v) PEG
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Agarose gel loading buffer (see 2.3.5):
2 % (w/v) orange G 
20 % (w/v) sucrose
Lysis buffer (see 2.4.2):
50 mM Tris-HCl pH 8.0
15 mM imidazole
2 mM DTT
5 mM MgCl2 
1 mM PMSF
Ni+2-NTA resin buffers (see 2.4.7):
Lysis buffer: 50 mM Tris-HCl pH 8.0
250 mM NaCl
20 mM imidazole
Washing buffer A: 50 mM Tris-HCl pH 8.0
400 mM NaCl
20 mM MgCl2
20 mM imidazole
Washing buffer B: 50 mM Tris-HCl pH 8.0
1.5 M NaCl
20 mM MgCl2
20 mM imidazole
Washing buffer C: 50 mM Tris-HCl pH 8.0
10 mM NaCl
20 mM MgCl2
20 mM imidazole
Elution buffer: 50 mM Tris-HCl pH 8.0
10 mM NaCl
20 mM Mg Cl2
200 mM imidazole
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Refolding buffers (see 2.4.11 and 2.4.12; annex 6):
Buffer 1: 50 mM MES pH 6.0
9.6 mM NaCl
0.4 mM KCl
2 mM MgCl2
2 mM CaCl2
0.75 M Guanidine HCl
0.5% Triton X-100
1 mM DTT
Buffer 2: 50 mM MES pH 6.0
9.6 mM NaCl
0.4 mM KCl
2 mM MgCl2
2 mM CaCl2
0.5 M arginine
0.05% polyethylene glycol 3,550
1 mM GSH
0.1 mM GSSH
Buffer 3: 50 mM MES pH 6.0
9.6 mM NaCl
0.4 mM KCl
1 mM EDTA
0.4 M sucrose
0.75 M Guanidine-HCl
0.5% Triton X-100
0.05% polyethylene glycol 3,550
1 mM DTT
Buffer 4: 50 mM MES pH 6.0
240 mM NaCl
10 mM KCl
2 mM MgCl2
2 mM CaCl2
0.5 M arginine
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0.5% Triton X-100
1 mM GSH
0.1 mM GSSH
Buffer 5: 50 mM MES pH 6.0
240 mM NaCl
10 mM KCl
1 mM EDTA
0.4 M sucrose
0.75 M Guanidine-HCl
1 mM DTT
Buffer 6: 50 mM MES pH 6.0
240 mM NaCl
10 mM KCl
1 mM EDTA
0.5 M arginine
0.4 M sucrose
0.5% Triton X-100
0.05% polyethylene glycol 3,550
1 mM GSH
0.1 mM GSSH
Buffer 7: 50 mM MES pH 6.0
240 mM NaCl
10 mM KCl
2 mM MgCl2
2 mM CaCl2
0.75 M Guanidine-HCl
0.05% polyethylene glycol 3,550
1 mM DTT
Buffer 8: 50 mM Tris-Cl pH 8.5
9.6 mM NaCl
0.4 mM KCl
2 mM MgCl2
2 mM CaCl2
0.4 M sucrose
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0.5% Triton X-100
0.05% polyethylene glycol 3,550
1 mM GSH
0.1 mM GSSH
Buffer 9: 50 mM Tris-HCl pH 8.5
9.6 mM NaCl
0.4 mM KCl
1 mM EDTA
0.5 M arginine
0.75 M Guanidine HCl
0.05% polyethylene glycol 3,550
1 mM DTT
Buffer 10: 50 mM Tris-HCl pH 8.5
9.6 mM NaCl
0.4 mM KCl
2 mM MgCl2
2 mM CaCl2
0.5 M arginine
0.4 M sucrose
0.75 M Guanidine-HCl
1 mM GSH
0.1 mM GSSH
Buffer 11: 50 mM Tris-HCl pH 8.5
9.6 mM NaCl
0.4 mM KCl
1 mM EDTA
0.5% Triton X-100
1 mM DTT
Buffer 12: 50 mM Tris-HCl pH 8.5
240 mM NaCl
10 mM KCl
1 mM EDTA
0.05% polyethylene glycol 3,550
1 mM GSH
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0.1 mM GSSH
Buffer 13: 50 mM Tris-HCl pH 8.5
240 mM NaCl
10 mM KCl
1 mM EDTA
0.5 M arginine
0.75 M Guanidine-HCl
0.5% Triton X-100
1 mM DTT
Buffer 14: 50 mM Tris-HCl pH 8.5
240 mM NaCl
10 mM KCl
2 mM MgCl2
2 mM CaCl2
0.5 M arginine
0.4 M sucrose
0.75 M Guanidine-HCl
0.5% Triton X-100
0.05% polyethylene glycol 3,550
1 mM GSH
0.1 mM GSSH
Buffer 15: 50 mM Tris-HCl pH 8.5
240 mM NaCl
10 mM KCl
2 mM MgCl2
2 mM CaCl2
0.4 M sucrose
1 mM DTT
Running buffer (see 2.4.4):
25 mM Tris-HCl pH 6.8
200 mM glycine
0.1 % (w/v) SDS
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SDS loading buffer (see 2.4.4):
50 mM Tris-HCl pH 6.8
2 % (w/v) SDS
0.1 % (w/v) bromophenol blue
10 % (v/v) glycerol
100 mM DTT
Strep-tag fusion proteins purification buffers (see 2.4.3):
Buffer W: 100 mM Tris-HCl pH 8.0
150 mM NaCl
1 mM EDTA
Elution buffer: 100 mM Tris-HCl pH 8.0
150 mM NaCl
1 mM EDTA
25 mM desthiobiotin
Regeneration buffer: 100 mM Tris-HCl pH 8.0
150 mM NaCl
1 mM EDTA
1 mM HABA
TAE buffer (see 2.3.5):
40 mM Tris-acetate pH 8.0 
1 mM EDTA
TLC buffer (see 2.4.3 and 2.5.4):
90 % (v/v) isopropanol
10 % (v/v) ammonium
Transfer buffer (see 2.4.5):
20 % (v/v) methanol
25 mM Tris-HCl pH 8.5
192 mM glycine
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Washing buffer (see 2.4.5):
400 mM NaCl
20 mM Tris-HCl pH 7.5
2 mM EDTA 
50 % (v/v) ethanol
2.2. Materials
Chemical Company Product code
φ X174 RF II DNA
New  England 
BioLabs
N3022S
Acetic acid Sigma 242853
Acetonitrile Fisher Scientific A/9627/17
Acrylamide Sigma A9926
2, 8- [3H] Adenine Perkin Elmer NET063005MC
*2, 8- [3H] Adenine Trisodium Salt
American 
Radiolabeld 
Chemicals
0386
Adenosine Sigma A9251
Adenosine di-phosphate Sigma A2754
Adenosine mono-phosphate Sigma A1752
Adenosine tri-phosphate (ATP) Sigma A6559
Agarose Bioline BIO-41026
Albumin, from bovine serum Sigma A7906
Amersham Hyperfilm ECLTM GE Healthcare® 28-9068-35
Ammonium hydroxide solution Sigma 221228
Ampicillin sodium salt Melford A0104
Antifoam A Sigma A-5633
Apyrase from potato Sigma A6535
BioTaqTM Red DNA Polymerase BioLine BIO-21041
Bovine serum albumin (BSA) Sigma C3411
Bradford Reagent Sigma B6916
Bromophenol blue Sigma B0126
Calcium chloride Sigma C1016
3-[(3-Cholamidopropyl) 
dimethylammonio]  -1- 
propanesulfonate  hydrate 
Sigma C9426
31
(CHAPS)
Chloramphenicol Sigma C0378
Coomasie G-250 Sigma 201391
Cytidine  5’-triphosphate  disodium 
salt
Sigma C1506
Dimethyl sulfoxide (DMSO) Sigma D2650
Dithiothreitol (DTT) Sigma 43817
DNA marker ladder Fermentas SM0311
ECLTM Western Reagent Amersham RPN2109
Ethanol Dep. Stores -
Ethidium bromide Sigma E7637
Ethylenediaminetetraacetic  acid 
(EDTA)
Sigma E6758
Glucose Sigma 158968
Glycerol Sigma G5516
Glycine Sigma 241261
Guanidine hydrochloride Sigma 1001176868
Guanosine 5’-triphosphate sodium 
salt hydrate
Sigma G8877
Hydrochloric acid Sigma H1758
HyperLadder I BioLine BIO-33025
Imidazole Sigma 15513
Instant blue Tripel Red -
Isopropyl  beta-D-thiogalactoside 
(IPTG)
Sigma I5502
Kanamycin monosulfate Melford K0126
L-Arginine Sigma 101147081
L-glutathione oxidized Sigma 1001095239
L-glutathione reduced Sigma 1001214749
Lysogeny broth (LB) medium Merck 10285.5000
Lysogeny broth (LB) agar Sigma L2897
Magnesium chloride Sigma M8266
Methanol Sigma M1775
2-Mercaptoethanol BDH 44143
Monoclonal  anti-glutathione-S-
transferase  (GST)  antibody 
produced in rat
Sigma SAB4200055
PagerulerTM  plus  pre-stained 
protein ladder
Fermentas SM0671
Phosphate buffered saline Sigma 79382
Polyethylene glycol 8000 (PEG) 
Fisher 
BioReagents
BP233-1
Potassium chloride Sigma P9333
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2-Propanol Sigma 443425
Poteinase K Sigma P6556
Rbt pAb to 6x His tag®, HRP abcam Ab1187-100
Sequi-BlotTMPlyvinylidene  Fluoride 
(PVDF) Membrane
Biorad 162-0184
Sodium chloride Sigma S7653
Sodium dodecyl sulphate (SDS) Sigma L3771
Spectinomycin  dihydrochloride 
pentahydrate
Fluka 85555
Streptomycin sulphate salt Melford S-6501
Sucrose Sigma P9333
Tetracycline Sigma T7660
Tetramethylethylenediamine 
(TEMED)
Sigma T9281
TLC  precoated  sheets 
PLYGRAM® Sil G
Machery-Nagel 805 013
Tris-HCl Sigma 93363
Triton X-100 Sigma T-8787
Trypsine, porcine Promega 608-274-4330
Tween-20 
(Polyoxyethylenesorbitan 
monolaurate)
Sigma P1379
Urea Sigma U5378
Uridine  5’-triphosphate  trisodium 
salt dihydrate
Sigma 94370
Kit Company Product code
QuickFoldTM Protein 
Refolding Kit
AthenaES 0600
Ni-NTA superflow resin Qiagen 30410
Wizard®  Plus Miniprep 
kit
Promega A7100
Zero  Blunt®  TOPO® 
PCR cloning kit
Invitrogen K2830-20
Cell lines Comapny Product code
E. coli BL21 (DE3) Novagen 69387
E. coli Mach1 T1 Invitrogen K2830-20
E. coli DH5α Invitrogen 12034-013
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 2.3. Cloning Procedures:
2.3.1 Polymerase chain reaction:
Reactions  using  Pfu DNA  polymerase  were  set  up  on  ice 
following the manufacturer’s protocol. Reactions typically contained 
20 mM Tris-HCl pH 8.8, 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 
1 % (v/v) Triton X-100, 0.1 mg mL-1 BSA, 25 pmoles of each primer, 
200  μM  dNTPs,  250  ng  DNA  template,  and  1  unit  Pfu DNA 
polymerase. Polymerase chain reaction (PCR) was typically cycled 
as listed below.
Time / minutes Temperature / °C
Initial denaturation 2 95
Denaturation 0.5 95
Annealing 0.5 55
Elongation 1 per 0.5 kb  73
Final Elongation 10 73
Cycling conditions for Pfu DNA polymerase.
2.3.2 Colony polymerase chain reaction:
Reactions using Taq DNA polymerase were set up on ice following the 
manufacturer’s  protocol.  Reactions  typically  contained  25  pmoles  of  each 
primer, 200 M dNTP, 1 unit of  Taq DNA polymerase. The DNA was 
introduced by touching the colony of interest with a pipette tip and 
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stirring it into the PCR tube. Polymerase chain reaction was typically 
cycled as listed below.
Time/minutes Temperature/°C
Initial denaturation 2 94
Denaturation 0.5 94
Annealing 0.5 60
Elongation 1 72
Final elongation 2 72
Cycling conditions for Taq DNA polymerase during a colony PCR
2.3.3 Gateway BP clonase II reaction:
75 ng of PCR product and 75 ng of the entry vector pDONR207 were 
incubated with 2 µg of BP clonase II in a total volume of 5 µL in TAE buffer 
(40 mM Tris-acetate pH 8.0, 1 mM EDTA). The reaction was incubated at 
room temperature for one hour and then 2  µg of proteinase K were added. 
The reaction was vortexed and left for 10 min at 37 oC. Bacterial cells were 
transformed with the reaction product (see 2.3.10).
2.3.4 Gateway LR clonase II reaction:
The  entry  vector  containing  the  PCR  fragment  was  purified  from 
positive  colonies  from  a  Gateway  BP  clonase  II  reaction  (see  2.3.3  and 
2.3.11).  75  ng  of  the  product  and  75  ng  of  the  destination  vector  were 
incubated with 2 µg of BP clonase II in a total volume of 5 µL, in TAE buffer 
(40 mM Tris-acetate pH 8.0, 1 mM EDTA). The reaction was incubated at 
room temperature for one hour and then 2  µg of proteinase K were added. 
The reaction was vortexed and left for 10 min at 37 oC. Bacterial cells were 
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transformed with the reaction product (see 2.3.10).
2.3.5 DNA purification from agarose gel:
1.5 % (w/v) or 1 % (w/v) agarose gels were run in TAE buffer (40 mM 
Tris-acetate, 1 mM EDTA pH 8.0) at 12 V cm-1. DNA sample was mixed at a 
ratio of 4:1 (sample:buffer) with loading buffer (2 % (w/v) orange G and 20 % 
(w/v)  sucrose  in  TAE  buffer  prior  to  loading.  DNA  sizes  were  estimated 
relative to a 1 kilobase DNA marker ladder. Visualisation of DNA was attained 
through the  in  gel  presence of  ethidium bromide (0.5  μg mL-1)  and a UV 
transilluminator.
2.3.6 Extraction of DNA from agarose gel:
DNA in agarose gels was visualized with a UV transilluminator and the 
band excised into a 1.5 mL tube. 1 mL of binding (6 M sodium perchlorate, 50  
mM Tris-HCl  pH 8.0,  10  mM EDTA) was  added and left  at  37 °C for  30 
minutes. 20  µL of 166 mg mL-1 silica were added, mixed for 30 minutes at 
room  temperature,  centrifuged  (12.000  g,  60  sec),  and  the  supernatant 
discarded.  The  pellet  was  resuspended  in  125  µL  of  binding  buffer  and 
centrifuged again. The supernatant was discarded and the pellet resuspended 
in 750 µL of wash buffer (400 mM NaCl, 20 mM Tris-HCl pH 7.5, 2 mM EDTA 
and 50 % (v/v)  ethanol). The sample was centrifuged and the supernatant 
discarded. The previous step was repeated once more and the pellet left to 
evaporate the remaining ethanol at room temperature for 5 minutes. 10 µL of 
ultra pure H2O were then added to the pellet. This was centrifuged once more 
and the supernatant was transferred to a new tube and stored at -20 °C.
2.3.7 Zero Blunt® TOPO® PCR cloning reaction:
36
The following reagents were added to a 1.5 mL tube.
pCR®-Blunt II-TOPO® vector 5 ng
Ligation Buffer 5 µL
DNA Insert > 20 ng
T4 DNA Ligase 3 U
Ligation buffer consisted of 60 mM Tris-HCl pH 7.8, 20 mM MgCl2, 20 
mM DTT, 2 mM ATP, and 10 % (w/v) PEG. Reactions were incubated for at 
least 15 min at room temperature in a final volume of 10 mL. 
2.3.8 Estimation of DNA concentration:
Concentrations of DNA in solution were determined by the use of a 
NanoDrop spectrophotometer  (BioLogic).  The blank used was  pure  water. 
DNA solutions were assumed to be largely free of contaminating proteins if 
the ratio of absorbance at 260:280 nm was > 1.6.
2.3.9 Restriction enzyme digest:
DNA  was  digested  with  restriction  enzymes  according  to  the 
manufacturers instructions. Enzyme concentration was maintained such that it 
was not greater than 10 % (v/v) of the total reaction volume.
2.3.10 Transformation of chemically competent cells:
25  µL  of  frozen  chemically  competent  cells  were  thawed  and 
transferred  into  ice.  DNA  was  added  to  thawed  cells.  The  cells  were 
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maintained on ice for 20 minutes before a heat shock in a 42 °C water bath for 
30 seconds and 2 minutes in ice. 0.5-1 mL of warm LB medium was added to  
the cells and the solution was introduced into a 14 mL tube and incubated at  
37 °C for  30-60 minutes with  shaking.  The cells  were  then centrifuged at 
2,500 g for 2 minutes. Most of the supernatant was discarded, leaving 1 mL to 
resuspend  the  pellet.  This  solution  was  then  spread  on  an  LB plate  and 
cultivated at 37 °C overnight. 
2.3.11 Purification of plasmid DNA:
Plasmid DNA was purified from 5 mL E. coli overnight cultures in LB 
medium  using  a  commercial  miniprep  kit  according  to  the  manufacturers 
instructions.
2.3.12 Preparation of competent E. coli cells with CaCl2:
5 mL of an overnight culture of E. coli grown in the appropriate medium 
were  transferred into  100 mL of  LB medium and incubated at  37 °C with  
agitation until the OD600nm  = 0.3-0.6. The cells were then transferred into ice-
cold 50 mL tubes and left on ice for 10 minutes. Cells were centrifuged at 
2,000 g for 10 minutes at 4 °C. The supernatant was discarded and the pellet  
mixed with 30 mL of 80 mM MgCl2/20 mM CaCl2. The solution was centrifuged 
again at 2,000 g for 10 minutes at 4 °C. The supernatant was discarded and 
the pellet mixed with 2 mL of ice-cold 0.1 M CaCl2 for each 50 mL of original 
culture. The cells were then used for transformation (see 2.3.10) or aliquoted 
with 20 % (v/v) glycerol and frozen at -80 °C. 
2.3.13 Preparation of bacterial -150 °C frozen stock:
E.  coli cells  were  grown  in  5  mL  of  LB  medium  containing  the 
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appropriate  antibiotics  at  37  °C  overnight.  Cells  were  harvested  by 
centrifugation (3,000 g for 5 minutes at 4 °C). The supernatant was discarded 
and the pellet resuspended in 1 mL of LB containing 20 % (v/v) glycerol. The 
suspension was placed in a labelled cryovial and stored at -150 °C.
2.4. Protein manipulation:
2.4.1 Expression of recombinant proteins in E. coli:
1 L LB medium was inoculated with  70 mL of  an overnight  E.  coli 
starter culture and grown in a 37 oC temperature controlled shaking incubator 
at 200 rpm. When cells reached an absorbance value of 0.8-0.9 at 600 nm, 
IPTG was added to the appropriate concentration. The culture was incubated 
shaking at 150 rpm for a predesignated time at an appropriate temperature. 
Bacteria were harvested through centrifugation (12,000 g, 4  oC, 7 min). The 
pellet corresponding to 2 L LB was washed with 40 mL bacterial wash buffer 
(50 mM Tris-HCl pH 8.5, 1mM EDTA), centrifuged (3,000 g, 4 oC, 25 min) and 
frozen at -80 oC until further use. 
2.4.2 Lysis of bacteria:
Frozen bacterial pellets (see 2.4.1) were thawed in a 37 oC water bath. 
Subsequent  steps were  performed on ice.  The pellet  was resuspended in 
twice its volume of lysis buffer (50 mM Tris-HCl pH 8.0, 15 mM imidazole, 2 
mM DTT, 5 mM MgCl2 and 1 mM PMSF). Cells were sonicated in 20 mL 
batches (2.5 min, 74 W, 2 pulses per second) and centrifuged (75,500 g, 60 
min). Crude supernatant containing soluble protein was saved for purification.
39
2.4.3 Strep-tag fusion protein purification with Strep-Tactin®:
All steps were performed on ice or at 4 oC. 1 mL of Strep-Tactin ® resin 
was used for every 30 mL of crude supernatant (see 2.4.2). The resin was 
pre-equilibrated with 5 mL of buffer W (100 mM Tris-HCl pH 8.0, 150 mM 
NaCl and 1 mM EDTA) and the crude supernatant was incubated with avidin 
(a biotin inhibitor from egg white) at room temperature for 10 minutes. The 
supernatant was left to drain by gravity. Prior to elution of the fusion protein, 
the column was washed with buffer W, 1.5 M NaCl. Protein was eluted with 3x 
0.5 mL of elution buffer (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM EDTA 
and 25 mM desthiobiotin). An aliquot of the eluate was analysed by SDS-
PAGE gel (see 2.4.4), the remainder was quantified (see 2.4.6), dialysed into 
dialysis buffer (50 mM Tris-HCl pH 8.0 and 15 mM NaCl), 20% (v/v) glycerol 
added and stored at -80 oC until further use. The resin was regenerated with 5 
mL of regeneration buffer (100 mM Tris-HCl pH 8.0, 150 mM NaCl, 1 mM 
EDTA and 1 mM HABA), reequilibrated with 8 mL of buffer W, and stored at 4 
oC with 1 mL of buffer W. 
2.4.4  Sodium  Dodecyl  Sulphate  Poly-Acrylamide  Gel  electrophoresis 
(SDS-PAGE):
Pre-cast 4-20% gradient SDS-PAGE gels (GE Healthcare) were used 
in  a horizontal  electrophoresis  system. Samples were mixed 1:2 (v/v)  with 
SDS loading buffer (50 mM Tris-HCl pH 6.8, 2% (w/v) SDS, 0.1% (w/v) bro-
mophenol blue, 10% (v/v) glycerol and 100 mM DTT) and run at 180 V cm -1 in 
running buffer  (25 mM Tris-HCl pH 6.8, 200 mM glycine, 0.1% (w/v) SDS). 
Protein sizes were estimated relative to a protein marker ladder. Gels were 
stained in Coomassie Instant Blue (Expedeon) and destained in distilled wa-
ter.
40
2.4.5 Western blot:
SDS-PAGE gels (see 2.4.4) were transferred onto an activated PDVF 
membrane (methanol 2 min) for 4 h at 75 V or for 2 h at 100 V and 4 oC in 
transfer  buffer  (20  %  (v/v)  methanol,  25  mM  Tris-HCl  pH  8.5,  192  mM 
glycine). Membranes were blocked with blocking buffer (50 mM Tris-HCl pH 
8.0, 30 mM NaCl, 0.2 % (v/v) Tween 20, 1.5 % (w/v) BSA and 5 % (w/v) milk 
powder)  for  16  h  at  4oC on a shaker  at  150 rpm.  Membranes were  then 
washed three times with 20 mL of 2x TBST buffer (50 mM Tris-HCl pH 8.0, 30 
mM NaCl and 0.2 % (v/v) Tween 20) for 5 min at room temperature with gen-
tle shaking. Membranes were then incubated for an hour in 10 mL of blocking 
buffer containing the HRP conjugated antibody in a dilution of 1:4,000 (v/v) at 
room temperature with gentle shaking. The membrane was washed four times 
with  2x TBST buffer  for  10 min at room temperature,  with  gentle shaking. 
Membranes were developed using ECLTM reagents and exposed to Hyperfilm 
ECLTM (GE Healthcare).
2.4.6 Estimating protein concentration:
Spectrophotometer:
The concentration of purified recombinant protein in solution was esti-
mated in an ultraviolet spectrophotometer according to the Beer-Lambert law 
and  an  estimated  protein  extinction  coefficient 
(http://www.biomol.net/en/tools/proteinextinction.htm).  The  absorbance  was 
measured at 280 nm and the buffer in which the protein was soluble was used 
as blank.
Bradford:
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90 µL of Quick StartTM Bradford were mixed with 10 µL of protein sam-
ple and incubated at room temperature for 5 minutes before reading the ab-
sorbance of  the solution at  595 nm with  a spectrophotometer.  A standard 
curve was made using known concentrations of BSA under the same condi-
tions as the sample. Sample absorbance was compared to this curve in order 
to know the concentration of the sample. 
2.4.7 His-tag fusion protein purification with Ni+2-NTA resin:
All steps were performed on ice or at 4 oC. 1 mL Ni+2-NTA resin (bind-
ing capacity of 5-10 mg mL-1) was used for every 30 mL of crude supernatant 
(see 2.4.2). The resin was preequilibrated with 5 mL of lysis buffer (50 mM 
Tris-HCl pH 8.0, 250 mM NaCl and 20 mM imidazole). The crude supernatant 
was incubated with the resin for 2 h, at 4 oC with gentle rocking before left to 
drain by gravity. Resin was washed with 15 mL (per 1 mL of Ni+2-NTA resin) 
wash buffer A (50 mM Tris-HCl pH 8.0, 400 mM NaCl, 20 mM imidazole and 
20 mM MgCl2); 15 mL (per 1 mL of Ni+2-NTA resin) wash buffer B (50 mM 
Tris-HCl pH 8.0, 1.5 M NaCl, 20 mM imidazole and 20 mM MgCl2); and 15 mL 
(per 1 mL of Ni+2-NTA resin) wash buffer C (50 mM Tris-HCl pH 8.0, 10 mM 
NaCl, 20 mM imidazole and 20 mM MgCl2). The protein was eluted with 5 mL 
(per 1 mL of Ni+2-NTA resin) elution buffer (50 mM Tris-HCl pH 8.0, 10 mM 
NaCl, 200 mM imidazole and 20 mM MgCl2). An aliquot of eluate was saved 
for analysis by SDS-PAGE (see 2.4.4). Eluate was dialysed into dialysis buffer 
(50 mM Tris-HCl pH8.0 and 15 mM NaCl), quantified, made up to 20% (v/v) 
glycerol, and stored at –80 oC until needed.
2.4.8 GST-tag fusion protein purification with Glutathione SepharoseTM:
All steps were performed on ice or at 4 oC. 250 µL of 50 % (v/v) Glu-
tathione Sepharose slurry (binding capacity of 8 mg mL -1) was used for every 
30 mL of crude supernatant (see 2.4.2). The slurry was preequilibrated with 2 
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mL of PBS previous to the incubation with the crude supernatant at room tem-
perature, for 1 h and with gentle rocking. After incubation, it was left to drain 
by gravity, washed with 2 mL of PBS and washed with 2 mL of washing buffer 
(50 mM Tris-HCl pH 8.0 and 200 mM NaCl). Tagged protein was eluted with 
4x100 µL of elution buffer (50 mM Tris-HCl pH 8.0 and 10 mM reduced glu-
tathione). Aliquots of the eluates were kept to analyse by SDS-PAGE gel. The 
remainder was dialysed into dialysis buffer, made up to 20 % (v/v) glycerol,  
quantified and frozen at -80 oC until further use. 
2.4.9 Determination of urea and NaCl concentrations for purification of 
inclusion bodies:
Frozen bacterial pellets (see 2.4.1) were thawed in a 37 oC water bath. 
Subsequent  steps were  performed on ice.  The pellet  was  resuspended in 
twice its volume of lysis buffer (50 mM Tris-HCl pH 8.0, 15 mM imidazole, 2 
mM DTT, 5 mM MgCl2 and 1 mM PMSF). Cells were sonicated in 20 mL 
batches (2.5 min, 74 W, 2 pulses per second) and centrifuged (75,500 g, 60 
min). Supernatant was discarded and pellets washed with 5 mL g -1 inclusion 
bodies washing buffer without urea (50 mM Tris-HCl pH 8.0, 500 mM NaCl, 1  
mM EDTA, 1 mg mL-1 deoxycholate). 100 µL of the solution was added to 7 
mL of inclusion bodies washing buffer with different urea (0 M, 2 M, 4 M, 6 M 
and 8 M urea) and NaCl (0 M, 1 M and 1.5 M NaCl) concentrations. The sam-
ples were mixed by vortexing and left at room temperature. After 30 minutes, 
they were centrifuged (maximum speed, 1 minute) and the supernatant was 
tested for the presence of soluble denatured protein. 
2.4.10 Purification of inclusion bodies after determining the appropriate 
urea and NaCl concentrations:
Frozen bacterial pellets (see 2.4.1) were thawed in a 37 oC water bath. 
Subsequent  steps were  performed on ice.  The pellet  was resuspended in 
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twice its volume of lysis buffer (50 mM Tris-HCl pH 8.0, 15 mM imidazole, 2 
mM DTT, 5 mM MgCl2 and 1 mM PMSF). Cells were sonicated in 20 mL 
batches (2.5 min, 74 W, 2 pulses per second) and centrifuged (75,500 g, 60 
min). Supernatant was discarded and pellets washed with 5 mL g -1 inclusion 
bodies washing buffer (50 mM Tris-HCl pH 8.0, 4 M urea, 500 mM NaCl, 1 
mM EDTA, 1 mg mL-1 deoxycholate), centrifuge at 20,000 g for 15 minutes at 
15 oC. The last two steps were repeated. The pellets were resuspended in 2 
mL g-1 solubilisation buffer (50 mM Tris-HCl pH 8.0, 4 M urea, 10 mM DTT) 
and left  for  20  minutes  at  50  oC before  centrifugation  at  20,000 g for  30 
minutes at 15  oC. Supernatant containing denatured protein was saved for 
refolding and purification of the protein.
2.4.11 Screening for refolding buffers:
After purification of inclusion bodies (see 2.4.10), 15 refolding buffers 
(Appendix 5) were tested to establish the best condition in which to refold the 
protein in use. Concentration of purified inclusion bodies was adjusted to 1 mg 
mL-1. 50 µL of these purified inclusion bodies were added slowly while vortex-
ing to 950 µL of each buffer and to 950 µL of inclusion bodies solubilisation 
buffer. They were incubated for an hour at 4  oC or 22  oC and centrifuged 5 
minutes at maximum speed. The supernatant was transferred into a new tube, 
reserving the pellet  in the old tube.  Successful  refolding was assessed by 
Western blot (see 2.4.5) of samples from soluble fractions. 
2.4.12 Protein refolding after determining the appropriate refolding buf-
fer:
950  µL of freshly made refolding buffer (50 mM Tris-HCl pH 8.5, 9.6 
mM NaCl,  0.4 mM KCl,  2 mM MgCl2,  2 mM CaCl2,  0.5 M arginine, 0.4 M 
sucrose, 0.75 M Guanidine-HCl, 1 mM GSH, 0.1 mM GSSH) were mixed with 
every 50 µL of denatured protein (see 2.4.9) at a concentration of about 1 mg 
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mL-1. The solution was vortexed and incubated at 4 oC for 1 h. The refolded 
protein  was  dialysed  into  dialysis  buffer  (50  mM Tris-HCl  pH 8.0,  15  mM 
NaCl), concentrated with PEG 8000, quantified and saved for further use. 
2.4.13 Dialysis:
Samples were introduced in a dialysis bag that had been previously 
boiled in distilled water. The dialysis bag was introduced in 1 L dialysis buffer  
(50 mM Tris-HCl pH 8.0 and 15 mM NaCl unless otherwise specified) with 
stirring for 1 h 30 minutes at 4 oC, changing the buffer every 15 minutes. 
2.4.14 Concentration with PEG 8000:
Samples in a dialysis bag were covered with PEG 8000 and left at 4 oC. 
Every 10 minutes, wet PEG 8000 was substituted by new PEG 8000. 
2.4.15 Electroelution:
20 cm long SDS-PAGE gels were run with samples containing dena-
tured protein. Bands corresponding to the correct size of the protein of interest 
were cut and introduced in a dialysis bag with running buffer to which 4 M 
urea was added to maintain the protein in a denatured state (avoiding the for-
mation of intermediate refolding states). Bags were then placed in an elec-
trophoresis tank with running buffer to which 4 M urea was also added. A low 
voltage current was applied during 4 h to elute the protein from the gel band 
and into the buffer in the dialysis bag. The solution was transferred into a tube 
and frozen at -20 oC until further use. 
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 2.5.Biochemistry:
2.5.1 Strict ATPase assay:
Soluble protein (see 2.4.12) was added to a total volume of 5 µL con-
taining 20 mM bis-Tris-Propane pH 7.5, 5 µM ATP and 10 mM MgCl2. Reac-
tions  were  spiked with  2,8-3  H-labeled adenine triphosphate  nucleotide  for 
quantitative biochemistry. The reaction was incubated for 1 h at 37  oC after 
which, the conversion of ATP into ADP was tested (see 2.5.3). 
2.5.2 Nucleotide phosphatase assay:
Soluble  protein  (see  2.4.12)  was  added  to  a  total  volume  of  5  µL 
containing 20 mM bis-Tris-Propane pH 7.5, 5  µM ADP and 10 mM MgCl2. 
Reactions were spiked with 2,8-3  H-labelled adenine diphosphate nucleotides 
for quantitative biochemistry. Reactions were incubated for 1 h at 37 oC, after 
which, the conversion of ADP into adenosine was tested (see 2.5.4).
2.5.3 Thin layer chromatography for strict ATPase assays:
1 µL of a strict ATPase reaction (see 2.5.1) was spotted onto a silica 
TLC plate with 0.8 µL of 2 mM ATP and 2 mM ADP spotted on top after drying 
to  act  as  a  marker  and  carrier.  The  plates  were  run  in  ATPase  assay 
developing  buffer  (15.5%  (v/v)  33%  (v/v)  aqueous  ammonia,  15.5%  (v/v) 
isobutyl-alcohol, 10.5% (v/v) isobutyl-ethanol, 31.5% (v/v) 2-etoxyethanol) for 
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2 h 30 minutes. After drying, spots were visualized with a TLC scanner at 256 
nm.
2.5.4 Thin layer chromatography for nucleotide phosphatase assays:
1 µL of an ADPase reaction (see 2.5.2) was spotted onto a silica TLC 
plate with 0.8 µL of 10 mM adenosine spotted on top after drying to act as a 
marker and carrier. The plates were run in ADPase assay developing buffer 
(9:1  isopropanol:33%  (v/v)  aqueous  ammonia).  After  drying,  spots  were 
visualized at 256 nm and excised for scintillation counting or visualized in a 
TLC scanner at 256 nm. 
2.5.5 Calculation of specific activities:
Strict  ATPase  or  nucleotide  phosphatase  specific  activities  were 
calculated from data obtained after measuring the results of a strict ATPase or 
a nucleotide phosphatase assay (see 2.5.1 and 2.5.2) with a TLC scanner 
(see 2.5.3 and 2.5.4).  When calculating strict  ATPase specific  activity,  the 
product  measured  was  ADP.  When  calculating  nucleotide  phosphatase 
specific  activity,  the  product  measured  was  Ado.  The equations  used  are 
shown below:
product recovered = counts – background
pmoles product = (product recovered / input) * pmoles substrate
pmoles  product  mg-1 min-1 =  (pmoles  product  /  minutes)  /  protein 
concentration (mg mL-1)
“Counts”: counts obtained from the area where the product appears in 
the reaction samples analysed.
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“Background”:  counts  obtained  from  the  area  where  the  product 
appears in the negative control.
“Input”: total counts obtained from the whole sample.
“Minutes”: time that the reaction was incubated, in minutes.
2.5.6 Viral dsDNA nicking:
0.5 µg of viral dsDNA were incubated for 1 h at 37 oC with 0.43 µg of 
soluble protein (see 2.4.12). After this, 5x STOP buffer (100 mM Tris-HCl pH 
8.0, 2.5 % SDS, 100 mM EDTA, 10 units µL -1 proteinase K) was added and 
the mix incubated for 15 minutes at 37  oC. The reaction was loaded on an 
agarose gel (see 2.3.5). Three negative controls were used: 0.5 µg of viral ds-
DNA, 0.5 µg of viral dsDNA with STOP buffer and 0.5 µg of viral dsDNA with 1 
µg of BSA and STOP buffer. As positive control 1 µg of DNAase I was added 
to 0.5 µg of viral dsDNA, maintaining the whole process as with the test pro-
tein. 
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3 Results
Resistance proteins in plants play an important role in plant innate immu-
nity (Belkhadir et al., 2004, Pan et al., 2000, Shen and Schulze-Lefert, 2007, 
Zipfel, 2008). They are immune receptors that can detect, directly or indirectly,  
isolate-specific pathogen effectors. Many and diverse studies have been con-
ducted on R proteins (Maekawa et al., 2011 and Zhang et al., 2010). Some 
groups have successfully expressed R protein domains and full  length pro-
teins (Bernoux et al., 2011, Maekawa et al., 2011, Schimdt et al., 2007, Ve et 
al., 2011, Willliams et al., 2011). Nevertheless, only one managed to produce 
soluble, active protein that was fully biochemically characterized (Fenyk et al., 
2012). Up to date, an R protein activation model has been accepted in which  
R proteins are strict ATPases. This is incongruent with findings in Fenyk et al., 
2012 where it is demonstrated that domains of R1, PSiP and Rpm1 (R pro-
teins  from rice,  maize  and  Arabidopsis,  respectively)  are  nucleotide  phos-
phatases. Understanding how these proteins function would provide informa-
tion of great importance for crop protection. In order to achieve this R1 and Rx 
(an R protein from potato that confers resistance against the Potato Virus X) 
constructs were used towards the creation of a methodology to obtain soluble,  
active R proteins as a first step for further investigations on their biochemical 
activity, structure and, finally, complete understanding of their role in plant in-
nate immunity.
3.1 Expression of Os025g25900 (R1)
A subdomain  of  an  orphan  resistance  protein  from  Oryza  sativa  ssp.  
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japonica Os025g25900  (R1)  had  been  previously  expressed  as  soluble 
protein (Fenyk  et al.,  2012). The R1 subdomain expressed corresponds to 
amino acids 197-339, an active nucleotide binding (NB) subdomain (R1-NB). 
As it was possible to express this resistance protein subdomain, new, bigger 
domains  were  created.  These constructs  included extra  C-terminus amino 
acids  (339-521)  in  the  case of  R1-NBARC (Appendix  1)  and  an extra  N-
terminus subdomain (145-197), in both R1-NBL and R1-NBARC (Appendix 1). 
These extra amino acids are thought to have a role in autoregulation of R 
proteins (Bendahmane et al., 2002; Bent, 1996, Hwang and Williamson, 2003; 
Hwang et al., 2000).
3.1.1 Expression constructs
Three strategies were used to generate recombinant plasmids expressing 
the open reading frames R1-NBL and R1-NBARC.
3.1.1.1 PCR and Zero Blunt® TOPO® cloning:
DNA  corresponding  to  amino  acids  145-521  of  R1  (R1-NBARC)  was 
amplified by PCR (see 2.3.1) using primers MJC188 and MJC522 (Appendix 
2). The PCR product was ligated into PCRTM-BluntII-TOPO (see 2.3.7) but 
no  recombinants  were  obtained  despite  repeated  attempts.  Resistance 
proteins hydrolyse nucleotides (Tameling et al., 2002). Residual expression of 
R1-NBARC  could  cause  the  death  of  the  cells  and,  therefore,  no  living 
recombinants would be recovered.
3.1.1.2 Subcloning:
pUC57 containing the complete R1 open reading frame was digested with 
XhoI and NdeI  (see 2.3.9) and the R1 insert ligated into  XhoI/NdeI  digested 
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pET-Strep3 (Dixon et al., 2009) but no recombinants were recovered despite 
repeated attempts. As before, in section 3.1.1.1, residual expression of an 
active  R1  domain  could  cause  the  death  of  recombinant  cells  due  to  its 
nucleotide hydrolysing activity (Tameling et al., 2002). 
3.1.1.3 Gateway:
DNA corresponding to amino acids 145-237 of R1 (R1-NBL) was amplified 
by PCR (see 2.4.1) using primers MJC541 and MJC540 (Appendix 2). DNA 
corresponding  to  R1-NBARC  was  amplified  using  primers  MJC535  and 
MJC540 (Appendix 2).  PCR products were  cloned into  the Gateway entry 
vector,  pDONR207,  using  BP  clonase  (see  2.3.3).  The  constructs  were 
purified  and  used  in  a  second  Gateway  reaction  (see  2.3.4)  where  the 
fragments were introduced in pCola2-DEST (pR1-NBL2, pR1-NBARC2) and 
pCola3-DEST (pR1-NBL3, pR1-NBARC3), using the LR clonase. Escherichia 
coli  BL21 (DE3) strains were satisfactorily transformed (see 2.3.10) carrying 
the  constructs  pR1-NBL2,  pR1-NBL3,  pR1-NBARC2  and  pR1-NBARC3 
(Appendix 1; Figure 7).
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R1-NBL 
R1-NBARC 
Figure 7 Colony PCR (see 2.3.2) of E. coli BL21 (DE3) strains with the expression vectors 1 
pR1-NBARC2,  2 pR1-NBL2,  3 pR1-NBARC3  and  4  pR1-NBL3.  The  primers  used  were 
MJC188 and MJC541 (for R1-NBL2 and R1-NBL3; Appendix 2) and MJC188 and MJC535 (for 
R1-NBARC2 and R1-NBARC3; Appendix 2).
As Figure 7 shows,  pR1-NBARC2, pR1-NBL2, pR1-NBARC3 and pR1-
NBL3 were successfully introduced into E. coli BL21 (DE3) strains, which then 
were ready to express proteins R1-NBARC and R1-NBL. The success in these 
transformations by gateway could be due to  the lack of expression of the 
constructs.
3.1.2 Expression of R1 subdomains as soluble proteins
Proteins  corresponding  to  R1-NBL2,  R1-NBL3,  R1-NBARC2  and  R1-
NBARC3 (Appendix  1)  carrying  a  N-terminal  hexa-histidine  tag  and  a  C-
terminal Strep tag were expressed (see 2.4.11) from E. coli BL21 (DE3). IPTG 
was used to induce the expression of these proteins once bacteria grew to an 
optical  density  of  0.8  at  a  wavelength  of  600 nm.  The  temperature,  after 
52
inducing protein expression, was either kept at 37 oC or lowered to 22 oC.
Despite multiple attempts, no soluble protein was recovered after purification 
with either Ni+2-NTA resin (see 2.4.7) or Glutathione SepharoseTM (see 2.4.8). 
In order to test for the expression of protein, Western blots (see 2.4.5) using 
cell lysate and soluble fraction samples were performed (Figure 8).
R1-NBL 
Unidentified non-specific band 
Figure 8 Anti-Strep Western blot (see 2.4.5) with cell lysate samples from E. coli BL21 (DE3) 
R1-NBL2 taken at different times after induction of protein expression with 100 µM IPTG. 1. 0 
h, 2. 30 minutes, 3. 1 h, 4. 1 h 30 minutes, 5. 2 h, 6. 2 h 30 minutes, 7. 3 h, 8. 3 h 30 minutes, 
9. 4 h, 10. 4 h 30 minutes, 11. 5 h, 12. o/n.
From Figure 8 we can infer the presence of R1-NBL2 (26 kDa) in the cell 
lysate between 2 h and 3 h and 30 minutes expression (Figure 8, 5-8), but no 
protein was ever seen in soluble fraction samples. These results could be due 
to the protein being expressed, but not refolding properly. Therefore, the use 
of chaperones was justified as a strategy to overcome this. Chaperones are 
proteins  that  enhance  other  proteins  solubility  by  promoting  their  correct 
refolding (Baneyx, 1999, de Marco et al., 2007 and Tomoyasu et al., 2001). It 
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is worth pointing out that the non-identified bands that appear in this figure 
could correspond to a R1-NBL2 dimmer as it has twice its size, its expression 
is  induced  by  IPTG  and  it  reacts  with  an  anti-Strep  specific  antibody. 
Nevertheless, this should be confirmed by mass spectrometry analysis.
3.1.3 Enhancement of R1 subdomains solubility with chaperones
No soluble proteins were recovered from the expression of R1-NBL2, R1-
NBL3,  R1-NBARC2  and  R1-NBARC3  by  conventional  means.  However, 
protein was present in cell lysates (see 3.1.2) and was hypothesized to be not 
folding properly. Therefore, the use of chaperones was tested. 
Chaperones  are  proteins  that  increase  other  protein’s  solubility  by 
promoting their correct folding (Baneyx, 1999, de la Fuente  et al., 2005, de 
Marco et al., 2007 and Tomoyasu et al., 2001). This has been demonstrated 
with different proteins, as seen in de Marco et al., 2007 and Tomoyasu et al., 
2001. In the case of resistance proteins, experiments shown by de la Fuente 
et al., 2005 demonstrate that resistance protein I-2, from tomato, requires the 
heat shock protein 90 (Hsp90) for its correct refolding and functioning. 
E. coli  BL21 (DE3) strains were transformed (see 2.3.10) with different 
chaperone vectors (Appendix 3) containing a series of  different  chaperone 
genes  including  danK,  dnaJ and  groELS (de  Marco  et  al.,  2007).  Eight 
different strains were created. These were then transformed (see 2.3.10) with 
the  constructs  pR1-NBL2,  pR1-NBL3,  pR1-NBARC2  and  pR1-NBARC3  to 
create thirty-two strains (Appendix 4). 
Positive  recombinants  (Appendix  4)  with  different  combinations  of 
chaperones  and  constructs  pR1-NBL2,  pR1-NBL3,  pR1-NBARC2 and pR1-
NBARC3 were used in expression tests. 50 mL LB medium was inoculated 
with 5 mL of an overnight culture and grown in a 37 oC temperature controlled 
shacking incubator at 200 rpm. When cells reached an absorbance value of 
0.8 at 600 nm, IPTG was added to a final concentration of 1 mM. The culture 
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was incubated by shaking at 150 rpm for 12 hours. Bacteria were harvested 
(see 2.4.1) and lysed (see 2.4.2). Western blots were performed to test the 
presence of R1-NBL2, R1-NBL3, R1-NBARC2 and R1-NBARC3. The samples 
used in Western blots were centrifuged supernatant to test for soluble proteins 
and cell lysates to test for soluble and insoluble proteins (Figure 9).
A B 
R1-NBL 
Unidentified non-specific band 
R1-NBARC 
Figure  9 Anti-His (A) and anti-Strep (B) Western blots (see 2.4.5) with cell lysate samples 
from E. coli BL21 (DE3) chaperone strains with R1 expression constructs. (A) 1. R1-NBL3 I, 2. 
R1- NBL3 II, 3. R1- NBL3 III, 4. R1- NBL3 IV, 5. R1- NBL3 V, 6. R1- NBL3 VI, 7. R1- NBL3 VII, 8. 
R1- NBL3 VIII. (B) 1. R1-NBARC2 I, 2. R1-NBARC2 II, 3. R1-NBARC2 III, 4. R1-NBARC2 IV, 
5. R1-NBARC2 V, 6. R1-NBARC2 VI, 7. R1-NBARC2 VII, 8. R1-NBARC2 VIII.
Figure 9 demonstrates the presence of correct size proteins for R1-NBL3 
(A weak band in lane 6, 26 kDa) and R1-NBARC2 (B 6-8, 48 kDa) in samples 
of cell  lysates obtained after their  expression from the different  chaperone 
strains. Chaperone strain VI supported the expression of protein for both R1-
NBL3 and  R1-NBARC2,  therefore  strains  R1-NBL3 VI  and R1-NBARC2 VI 
were chosen for further analysis. 
For  both  strains,  R1-NBL3 VI  and R1-NBARC2 VI,  an  expression  test 
experiment  was conducted.  Four 50 mL LB medium flasks for each strain 
were  inoculated with  5  mL of  an  overnight  culture  and grown in  a  37  oC 
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temperature controlled shaking incubator at 200 rpm. When cells reached an 
absorbance  value  of  0.8  at  600  nm,  IPTG  was  added  to  two  different 
concentrations: 100  µM and 1 mM. The culture was incubated for 12 hours 
during which, the temperature was maintained at 37 oC or lowered to 22 oC. 
Bacteria were harvested (see 2.4.1) and lysed (see 2.4.2). Western blots were 
performed  to  test  the  presence  of  R1-NBL3  VI  and  R1-NBARC2 VI.  The 
samples  used  in  Western  blots  were  centrifuged  supernatant  to  test  for 
soluble proteins (Figure 10) and cell lysates to test for soluble and insoluble 
proteins (Figure 11).
A B 
R1-NBL 
R1-NBARC 
Figure  10 Anti-Strep Western blots (see 2.4.5) with soluble fraction samples from (A) R1- 
NBL3 VI and (B) R1-NBARC2 VI expressing protein under different conditions.  +. F2, GST 
protein in Arabidopsis (Dixon et al., 2009); 1. 22 oC, 100 µM IPTG, 3 h; 2. 22 oC, 1 mM IPTG, 
3 h; 3. 22 oC, 100 µM IPTG, o/n; 4. 22 oC, 1 mM IPTG, o/n; 5. 37 0C, 100 µM IPTG, 3 h; 6. 37 
0C, 1 mM IPTG, 3 h; 7. 37 0C, 100 µM IPTG, o/n; 8. 37 0C, 1 mM IPTG, o/n.
A B 
R1-NBARC 
R1-NBL 
Unidentified non-specific band 
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Figure 11 Anti-Strep Western bolts (see 2.4.5) with total fraction samples from (A) R1- NBL3 
VI and (B) R1-NBARC2 VI expressing protein under different conditions.1. 22  oC, 100  µM 
IPTG, 3 h; 2. 22 oC, 1 mM IPTG, 3 h; 3. 22 oC, 100 µM IPTG, o/n; 4. 22 oC, 1 mM IPTG, o/n; 
5. 37 0C, 100 µM IPTG, 3 h; 6. 37 0C, 1 mM IPTG, 3 h; 7. 37 0C, 100 µM IPTG, o/n; 8. 37 0C, 1 
mM IPTG, o/n.
Comparison of the above Westerns blots (Figure 10 and Figure 11) shows 
that R1-NBL3 and R1-NBARC2 were being expressed, but were not soluble 
as both proteins show bands in Westerns blots with samples of cell lysates, 
but  not  with  soluble  fractions.  Chaperones  do  not,  therefore,  improve  the 
solubility  of  either  protein.  As  the  proteins  were  being  expressed,  albeit 
insoluble, a different approach was implemented to refold insoluble proteins 
by testing different refolding conditions.
A  refolding  protocol  was  used  with  I-2  (Tameling  et al.,  2002).  This 
resistance protein was expressed in bacteria and accumulated in inclusion 
bodies.  Purification of inclusion bodies, solubilisation of the proteins in the 
inclusion bodies with high concentrations of urea, and posterior refolding of I-2 
resulted  in  active  protein.  Following  this  way  of  proceeding,  a  series  of 
refolding conditions (Appendix 5) was tested for R1-NBARC2. This was the 
construct chosen as it is bigger than R1-NBL and more closely represents a 
suitable target for biochemistry.
3.1.4 Refolding of R1-NBARC2
In  section  3.1.2  it  was  shown  that  R1-NBL and  R1-NBARC  are  not 
expressed as soluble proteins in  E. coli BL21 (DE3) strains although these 
proteins were present in total lysates (Figure 8). The use of chaperones to 
improve  their  solubility  did  not  give  soluble  protein  either  (Figure  10). 
However,  R1-NBL and  R1-NBARC  were  always  present  in  total  lysates 
(Figure  11).  As  an  approach  towards  refolding  insoluble  R1-NBARC2, 
inclusion bodies were purified from E. coli BL21 (DE3) strains and the protein 
was subjected to different refolding conditions (Appendix 5). This protocol has 
proved to yield active, soluble protein in other experiments (Rudolph and Lilie, 
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1996). 
Inclusion bodies are relatively simple to purify,  but the protein must be 
recovered from the insoluble fraction and refolded into an active protein. To 
achieve this, the protein first has to be solubilized by denaturation (Rudolph 
and Lilie, 1996). It is then necessary to test different conditions in order to 
identify which will provide soluble active protein. 
R1-NBARC2 was expressed and the inclusion bodies purified. Different 
urea  and  NaCl  concentrations  were  tested  (see  2.4.9)  to  establish  the 
concentration needed in the solubilisation buffer (Figure 12): the highest urea 
and NaCl concentration that does not solubilize the protein from the inclusion 
bodies.
A B 
R1-NBARC 
Unidentified non-specific band 
R1-NBARC 
Figure 12 Anti-His Western blots (see 2.4.5) with soluble fraction samples from E. coli BL21 
(DE3) R1-NBARC2. Different concentrations of urea and NaCl were tested for the purification 
of inclusion bodies. (A)  1. 0 M urea, 0 M NaCl;  2. 0 M urea, 1 M NaCl;  3. 0 M urea, 1.5 M 
NaCl; 4. 2 M urea, 0 M NaCl; 5. 2 M urea, 1 M NaCl; 6. 2 M urea, 1.5 M NaCl; 7. 4 M urea, 0 
M NaCl; 8. 4 M urea, 1 M NaCl; 9. 4 M urea, 1.5 M NaCl. (B) 1. 6 M urea, 0 M NaCl; 2. 6 M 
urea, 1 M NaCl; 3. 6 M urea, 1.5 M NaCl; 4. 8 M urea, 0 M NaCl; 5. 8 M urea, 1 M NaCl; 6. 8 
M urea, 1.5 M NaCl.
Results in Figure 12 show that the highest urea and NaCl concentrations 
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that do not solubilize the protein are 4 M urea and 1.5 M NaCl as no bands 
can be seen on the SDS-PAGE gel that corresponds to Figure 12 A, but are 
visible  on  Figure  12,  B.  These  are  the  concentrations  used  in  the 
solubilisation  buffer  when  performing  the  refolding  experiment  for  R1-
NBARC2.
Once the concentrations of urea and NaCl were determined, a screen of 
15 different refolding conditions was performed (see 2.4.11; Appendix 5). The 
presence of soluble protein in those samples was tested by Western blot (see 
2.4.5, Figure 13).
A B 
R1-NBARC R1-NBARC 
Unidentified non-specific band 
Figure  13 Anti-His Western blots (see 2.4.5) with soluble fraction samples of purified and 
solubilized inclusion bodies from  E. coli BL21 (DE3) R1-NBARC2 under different refolding 
conditions (Appendix 5). (A) +. Catabolite activator protein (CAP), His tagged protein from E. 
coli, 1. Purified inclusion bodies, 2. Solubilized inclusion bodies, 3. Refolding condition 1 after 
dialysis,  4.  Refolding condition 8 after dialysis,  5.  Refolding condition 11 after dialysis,  6. 
Refolding condition 1, 7. Refolding condition 2, 8. Refolding condition 3, 9. Refolding condition 
4,  10.  Refolding condition 5,  11.  Refolding condition  6,  12.  Refolding condition 7.  (B)  1. 
Solubilized inclusion bodies,  2. Refolding condition 8, 3. Refolding condition 9, 4. Refolding 
condition 10, 5. Refolding condition 11, 6. Refolding condition 12, 7. Refolding condition 13, 8. 
Refolding condition 14, 9. Refolding condition 15.
Although there is protein in the purified and solubilized inclusion bodies 
(Figure 13  A 1-2,  B 1),  no protein is present in the soluble fractions after 
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refolding  with  each  of  the  different  conditions  (Figure  13  A  6-12,  B 2-9; 
Appendix 5). Some samples were dialysed (Figure 13  A 3-5) to eliminate a 
possible negative interaction of salts during Western blotting. Having in mind 
these results, it is inferred that no soluble protein was obtained with any of the 
15 different refolding conditions. 
Results from sections 3.1.2, 3.1.3 and 3.1.4 showed that no soluble active 
protein  was  ever  recovered  despite  multiple  different  approaches.  No 
attempts to improve the solubility of proteins R1-NBL and R1-NBARC were 
successful. There is evidence of expression of these proteins in cell lysates,  
although no soluble, active protein could be recovered. Resistance proteins 
like R1 hydrolyse nucleotides (Tameling  et al., 2002) and this could be the 
reason why it is not possible to obtain active proteins from their expression in  
cells. Other reasons to why these proteins are toxic that cannot be ruled out 
are that R proteins bind DNA and affect transcription (Choi  et al., 2001 and 
Wang et al., 2010). Moreover, R proteins could have other unknown activities 
that result in their toxicity to cells. 
Refolding insoluble, inactive protein from expressing bacteria could be an 
option towards the achievement of recovering soluble, active, toxic proteins. 
Nevertheless, this approach did not give positive results with R1-NBARC. As 
resistance proteins have highly conserved structures, the project moved on 
towards the test of these refolding conditions on Rx (Appendix 5), the potato 
resistance protein  against  Potato  Virus  X  (PVX).  Rx has  been  thoroughly 
studied although it  has not yet  been produced as a soluble active  protein 
(Bendahmane et al., 1995; Goulden et al., 1993 and Kohm et al., 1993).
3.2 Expression of the Potato Virus X (PVX) resistance gene (Rx)
As no soluble R1 protein was ever recovered despite the use of different 
approaches (see 3.1),  the  Rx resistance protein  from potato,  which  infers 
resistance against  Potato Virus X,  was used.  Two versions of  Rx-NBARC 
were used,  wild  type and K176R mutant  (Rx-NBARC WT and Rx-NBARC 
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K176R  respectively,  obtained  from  Dr.  F.  L.  W.  Takken).  It  has  been 
demonstrated in other resistant proteins (Takken et al., 2006) that this type of 
mutation in the P-loop causes a loss-of-function phenotype.
3.2.1 Protein refolding of Rx:
Amino acids 1-486 of Rx (Rx-NBARC) in the expression vector pGEX-4T-
1 were expressed in E. coli BL21 (DE3) strains (see 2.4.2). Pellets were lysed 
(see 2.4.3) and used for purification of inclusion bodies. Two versions of Rx-
NBARC were used: the wild type and a K176R mutant (Rx-NBARC WT and 
Rx-NBARC K176R, respectively).
3.2.1.1 Test of refolding conditions for Rx-NBARC
Different  urea  and  NaCl  concentrations  were  tested  (see  2.4.9)  to 
establish the highest concentration that would not solubilize Rx-NBARC. This 
concentration was established as 4 M urea and no NaCl.
After the concentrations of urea and NaCl were determined, a screening 
of 15 different refolding conditions was performed (see 2.4.11; Appendix 5). 
The  presence  of  soluble  protein  was  tested  by  Western  blot  (see  2.4.5). 
Preliminary activity assays were performed in order to identify the condition 
that allowed recovery of the largest amount of soluble protein in an active 
conformation.
Resistance proteins in plants are thought to act as ATPases in an “on-off” 
switch (Bisgrove et al., 1994; Takken et al., 2006 and Tameling et al., 2002). 
The current model of activation for plant resistance proteins hypothesizes that 
they attain their active state when an ATP molecule is bound to their NBARC 
domain. The hydrolysis of this ATP molecule into ADP (strict ATPase activity) 
would  cause  a  conformational  change  in  the  protein,  making  it  enter  its 
inactive state (Takken et al., 2006 and Tameling et al., 2002). Strict ATPase 
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activity  assays  (see 2.5.1)  were  therefore  conducted to  monitor  Rx for  its 
correctly  folded  state  (Figure  14).  However,  a  recent  study (Fenyk  et al., 
2012) demonstrated that the NB subdomain of R1 (orphan resistant protein of 
Oryza  sativa  ssp.  japonica  Os025g25900)  has  a  nucleotide  phosphatase 
activity with preference of substrate as follows: AMP>ADP>ATP. This is the 
only evidence of this activity in plant resistance proteins to date, but it is also  
the  first  time  ever  a  soluble,  active  resistance  protein  domain  has  been 
expressed  and  fully  biochemically  characterized.  Following  this  line  of 
investigation, nucleotide phosphatase activity tests using ADP as substrate 
(see 2.5.2) were also performed on refolded Rx-NBARC samples (Figure 15).
1 3 5 8 9 1 0 1 1 1 2 1 5
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0 . 1 5
Figure  14 Results  from  a  strict  ATPase  assay  (see  2.5.1)  with  Rx-NBARC  WT under 
different refolding conditions (Appendix 5). 1. Refolding condition 1, 3. Refolding condition 3, 
5.  Refolding condition 5,  8.  Refolding condition 8,  9.  Refolding condition 9,  10.  Refolding 
condition 10,  11. Refolding condition 11, 12. Refolding condition 12, 15. Refolding condition 
15. The product searched for was ADP. Data was read with a scintillation counter. Error bars 
correspond to the standard deviation (n=2).
Strict ATPase reactions performed to create Figure 14 were conducted as 
explained in 2.5.1, reactions were developed as in 2.5.3 and specific activities 
were calculated as in 2.5.5.
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Figure 15 Results from a nucleotide phosphatase assay (see 2.5.2) with ADP as substrate 
and Rx-NBARC WT under different refolding conditions (Appendix 5).  1. Refolding condition 
1,  2. Refolding condition 2,  3. Refolding condition 3,  4. Refolding condition 4,  5. Refolding 
condition 5,  6. Refolding condition 6,  7. Refolding condition 7,  8. Refolding condition 8,  9. 
Refolding condition 9,  10. Refolding condition 10,  11. Refolding condition 11,  12. Refolding 
condition 12,  13. Refolding condition 13, 14. Refolding condition 14, 15. Refolding condition 
15. The product searched for was adenosine. Data was read with a scintillation counter. Error 
bars correspond to the standard deviation (n=2). 
The samples used to create Figure 15 were those used in Figure 14. In 
this  case,  the  spots  were  developed  with  a  nucleotide  phosphatase 
developing buffer instead of a strict ATPase developing buffer (see 2.5.4) and 
specific activities were calculated as in 2.5.5.  Differences of strict  ATPase 
activity and phosphatase activity using the same protein sample, but varying 
the refolding conditions might be in those refolding conditions. The protein can 
not refold properly under all conditions. Some refolding buffers may enhance 
a correct refolding of Rx-NBARC, while others do not. 
From Figures 14 and 15, it can be shown that refolding buffer number 10 
(Appendix 5) provides the best conditions for Rx-NBARC WT to refold. It can 
also  be  stated  that  the  refolded  Rx-NBARC  had  a  higher  nucleotide 
phosphatase activity than strict ATPase activity. Buffers 9 and 10 were then 
tested with both the wild type and the K176R mutant versions of Rx-NBARC. 
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3.2.1.2 Comparison of successful refolding conditions for Rx-NBARC
Proteins Rx-NBARC WT and Rx-NBARC K176R were refolded with buffer 
9 and buffer  10 (Appendix 5).  Their  nucleotide phosphatase activities with 
ADP  as  substrate  were  tested  through  a  nucleotide  phosphatase  activity 
assay (see 2.5.2, Figure 16).
Figure  16 Results from a nucleotide phosphatase activity assay (see 2.5.2) with ADP as 
substrate and samples of Rx-NBARC WT and Rx-NBARC K176R refolded with buffer 9 and 
10. The product searched for was adenosine. Data was read with a scintillation counter.
From Figure 16 it can be inferred that the buffer that yields more active 
protein for both wild type and mutant Rx-NBARC is buffer 10. This Figure was 
created with data from preliminary nucleotide phosphatase experiments with 
refolded samples of Rx-NBARC WT and Rx-NBARC K176R that had not been 
purified further than an inclusion bodies purification (see 2.4.10). It cannot be 
used  as  definitive  specific  activity  data  to  compare  differences  between 
proteins; therefore differences (or lack of them) in activity between wild type 
and mutant Rx are unreliable. Specific experiments with cleaner samples are 
shown later (Figure 26 and Figure 36). 
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3.2.2 Protein purification after refolding
Rx-NBARC  WT  and  Rx-NBARC  K176R  were  purified  from  inclusion 
bodies  (see  2.4.10),  refolded  using  buffer  10  (see  2.4.12),  dialysed  (see 
2.4.13)  and concentrated  with  PEG 8000 (see 2.4.14).  After  this  process, 
samples were ready for purification.
Rx-NBARC WT and Rx-NBARC K176R constructs had a glutathione S-
transferase (GST) tag on the N-terminus and a hexa-histidine tag on the C-
terminus.  Each  tag  was  used  for  purification  tests  on  a  Glutathione 
SepharoseTM purification (see 2.4.8) and a Ni+2-NTA resin (see 2.4.7) after Rx-
NBARC WT and Rx-NBARC K176R were refolded (see 2.4.12), dialysed (see 
2.4.13) and concentrated (see 2.4.14). 
3.2.2.1 Glutathione SepharoseTM purification:
Rx-NBARC  constructs  had  a  N-terminal  GST  tag  that  was  used  for 
purification with a Glutathione SepharoseTM resin after the protein had been 
refolded, dialysed and concentrated.
Nucleotide phosphatase activity (see 2.5.2 and 2.5.4) was tested in the 
buffers  used  during  the  purification  of  inclusion  bodies,  refolding  and 
Glutathione SepharoseTM purification processes (Figure 17).
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Figure  17 Nucleotide  phosphatase  activity  present  in  different  buffers  used  during  the 
inclusion bodies purification, refolding and Glutathione SepharoseTM purification processes. 
ADP was used as substrate and the product searched for was adenosine. Data was read with  
a  TLC scanner.  Blue  areas  correspond  to  ADP,  red  to  adenosine.  (A)  Positive  control: 
refolded,  non-purified Rx-NBARC WT. (B)  Inclusion bodies washing buffer.  (C)  Refolding 
buffer 10. (D) Dialysis buffer. (E) PBS. (F) Glutathione SepharoseTM elution buffer.
Figure 17 shows that no nucleotide phosphatase activity is observed in 
substances  in  the  buffers  used  for  the  purification  of  inclusion  bodies,  
refolding Rx-NBARC, or for Glutathione SepharoseTM purification.
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Refolded  Rx-NBARC  WT  and  Rx-NBARC  K176R  (see  2.4.12)  were 
subjected to a Glutathione SepharoseTM purification (see 2.4.8).  Nucleotide 
phosphatase assays (see 2.5.2) were conducted on all samples obtained from 
these purifications (Figures 18 and 19).
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Figure 18 Nucleotide phosphatase assay (see 2.5.2) with ADP as substrate and Rx-NBARC 
WT samples obtained during a Glutathione SepharoseTM purification (see 2.4.8). Data was 
read with a TLC scanner.  Blue areas correspond to ADP, red to adenosine.  (A)  Positive 
control, R1-NB (Fenyk et al., 2012). (B) Flow through. (C) Wash one (2 mL PBS). (D) Wash 
two (2 mL washing buffer). (E) Eluate one (200 µL of elution buffer). (F) Eluate two (200 µL of 
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elution buffer).
Figure  19 Nucleotide phosphatase assay (see 2.5.2) with ADP used as substrate and Rx-
NBARC K176R samples obtained during a Glutathione SepharoseTM purification (see 2.4.8). 
Data was read with a TLC scanner. Blue areas correspond to ADP, red to adenosine. (A) 
Positive control, Rx-NBARC WT refolded, non-purified. (B) Flow through. (C) Wash one (2 mL 
PBS). (D) Wash two (2 mL washing buffer). (E) Wash three (2 mL PBS). (F) Eluate one (150 
µL elution buffer). (G) Eluate two (150  µL elution buffer). (H) Eluate three (150  µL elution 
buffer).
Nucleotide phosphatase assays (see 2.5.2) performed to create Figures 
17 and 18 used ADP as substrate with adenosine analysed as product. Data 
on Figures 18 and 19 show that nucleotide phosphatase activity was present 
mainly  in  the  flow  through  samples.  No  active  phosphatase  protein  was 
recovered in eluates. SDS-PAGE gels (see 2.4.4, Figure 20) and Western 
blots (see 2.4.5, Figure 21) were performed with these samples, but bands 
corresponding to the correct Rx-NBARC size (75 kDa) were only present in 
flow throughs, consistent with the data of the activity assays (Figures 18 and 
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19).
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Unidentified non-specific band 
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Figure 20 SDS-PAGE gel with samples of (A) Rx-NBARC WT and (B) Rx-NBARC K176R 
from a Glutathione SepharoseTM purification (see 2.4.8). (A) 1. Flow through, 2. Wash one (2 
mL PBS),  3. Wash two (2 mL washing buffer),  4. Eluate one (200  µL of elution buffer),  5. 
Eluate two (200 µL of elution buffer). (B) 1. Refolded, non-purified Rx-NBARC K176R, 2. Flow 
through, 3. Wash one (2 mL PBS), 4. Wash two (2 mL washing buffer), 5. Wash three (2 mL 
PBS),  6.  Eluate one (150  µL of elution buffer),  7. Eluate two (150  µL of elution buffer),  8. 
Eluate three (150 µL of elution buffer).
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Figure 21 Anti-His (A) and anti-GST (B) Western blots (see 2.4.5) with samples of (A) Rx-
NBARC WT and (B)  Rx-NBARC K176R from a Glutathione SepharoseTM purification (see 
2.4.8). (A) +. CAP, His-tagged protein from E. coli, 1. Refolded, non-purified Rx-NBARC WT, 
2. Flow through, 3. Wash one (2 mL PBS), 4. Wash two (2 mL washing buffer), 5. Wash three 
(2 mL PBS),  6. Eluate (150  µL elution buffer). (B)  +. F2, GST-tagged protein (Dixon  et  al., 
2004),  1.  Refolded, non-purified Rx-NBARC K176R,  2.  Flow through,  3.  Wash one (2 mL 
PBS),  4. Wash two (2 mL washing buffer),  5. Wash three (2 mL PBS),  6. Eluate (150  µL 
elution buffer).
Figures  18-21  demonstrate  that  no  protein  was  recovered  from 
Glutathione SepharoseTM purifications (see 2.4.8)  despite  modifying  elution 
and incubation conditions. The reason why Rx-NBARC did not bind to the 
resin through its GST N-terminus tag might be because the resin was not 
functioning  correctly  under  the  experimental  conditions  used.  A  different 
possibility  could  be  that  the  buffers  used for  refolding  and  dialysing  were 
interfering with the purification process. The third possibility for the GST tag 
not binding to the glutathione SepharoseTM resin was that it was not refolding 
properly or it was situated in a position where the binding was obstructed. In 
order to check these possibilities, a test glutathione SepharoseTM purification 
(see 2.4.8) was conducted with GST.
70
Proof of efficiency of the Glutathione SepharoseTM resin:
No Rx-NBARC WT or Rx-NBARC K176R was recovered from eluates and 
most of it was coming out in the flow through on purification. In order to know 
if  the  resin  was  working  or  if  any  of  the  steps  of  the  experiments  were 
preventing the GST tag in the Rx-NBARC proteins from binding to the resin, 
the same process was performed with naked GST. Consequently, GST was 
subjected to the expression, purification and refolding process to which Rx-
NBARC had been previously. 
GST was expressed from an empty pGEX-6P-1 plasmid (GE Healthcare) 
in  E.  coli  BL21  (DE3).  After  harvesting,  soluble  protein  from lysates  was 
purified in a Glutathione SepharoseTM resin (see 2.4.8, Figure 22).
GST 
Figure  22 SDS-PAGE gel with samples of GST (26 kDa) from a Glutathione SepharoseTM 
purification  (see  2.4.8).  1.  Pellet  after  harvesting,  2.  Cell  lysate  after  sonication,  3.  Flow 
through, 4. Wash one (2 mL PBS), 5. Wash two (2 mL washing buffer), 6. Wash three (2 mL 
PBS), 7-10. Eluates (500 µL elution buffer each).
Figure 22 displays that, although some GST was lost on the flow through 
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and washes, most of it was bound to the Glutathione SepharoseTM resin and 
was  eluted  (Figure  22,  7-10).  The  loss  of  GST  on  the  first  steps  of  the 
purification could be due to  a saturation of  the resin  because of  the high 
concentration of GST in the sample. 
An  aliquot  of  purified  GST was  denatured  and  refolded  with  refolding 
buffer 10 (see 2.4.12) as Rx-NBARC proteins were. After this, it was dialysed 
(see  2.4.13).  A  second aliquot  was  denatured and  refolded with  refolding 
buffer 10, as Rx-NBARC proteins, but this time, substituting 1 mM GSH and 
0.1 mM GSSH for 1 mM DTT. This sample was dialysed too. A third sample 
was directly dialysed,  without  being denatured. These three samples were 
used in three Glutathione SepharoseTM purifications (see 2.4.8) performed at 
the same time. The presence of protein in the eluates obtained from each of 
the three purifications was checked with a Bradford experiment (see 2.4.6). 
The results were positive for the three conditions.
This  experiment  demonstrates  that  the  Glutathione  SepharoseTM resin 
was in good condition and that the experimental processes before purification 
were not interfering with purification. The last explanation possible was that 
either the GST tag was not refolded properly when attached to Rx-NBARC or 
Rx-NBARC was sterically inhibiting GST binding to the resin. Nevertheless, 
this  was  not  explained  with  this  experiment  and  no  other  trials  were 
conducted. It, therefore, remains as an open question with no answer. Focus 
was moved towards a different approach so as to purify Rx-NBARC WT and 
Rx-NBARC K176R using their  C-terminal  hexa-histidine tag on a Ni+2-NTA 
resin purification (see 2.4.7)
3.2.2.2 Ni+2-NTA resin purification:
Purification  with  Glutathione  SepharoseTM  after  refolding,  dialysing  and 
concentrating Rx-NBARC constructs did not work: the protein did not bind to 
the beads and was observed in the flow through. As a different approach, a 
Ni+2-NTA resin purification (see 2.4.7) was performed with Rx-NBARC WT. 
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Rx-NBARC constructs have a C-terminal hexa-histidine tag that should make 
possible their purification using this method. Nevertheless, no better results 
were  obtained  from  a  Ni+2-NTA  resin  purification  than  those  from  a 
Glutathione  SepharoseTM.  Nucleotide  phosphatase  activity  (see  2.5.2)  was 
examined in the samples from a Ni+2-NTA purification (see 2.4.7, Figure 23) 
with Rx-NBARC WT and a Western blot was conducted (see 2.4.5, Figure 
24).
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Figure 23 Nucleotide phosphatase assay (see 2.5.2) with Rx-NBARC WT samples obtained 
during a Ni+2-NTA resin purification (see 2.4.7). Data was read with a TLC scanner. Blue 
areas correspond to ADP, red to adenosine. (A) Positive control: refolded, non-purified Rx-
NBARC WT. (B) Flow through. (C) Wash one (15 mL wash buffer A). (D) Wash two (15 mL 
wash buffer B). (E) Wash three (15 mL wash buffer C). (F) Eluate (5 mL elution buffer).
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Figure  24 Anti-His Western blot (see 2.4.5) with samples from a Ni-NTA resin purification 
(see 2.4.7) of Rx-NBARC WT.  + CAP, His-tagged protein from  E. coli,  1.  Rx-NBARC WT 
purified, solubilized inclusion bodies, 2. Flow through, 3. Wash one (15 mL wash buffer A), 4. 
Wash two (15 mL wash buffer B),  5. Wash three (15 mL wash buffer C),  6. Eluate (5 mL 
elution buffer).
It is evident from Figures 23 and 24 that Rx-NBARC WT was being lost on 
the flow through and washes. The protein would not bind the Ni+2-NTA resin. 
A  possible  explanation  to  why  Rx-NBARC  was  not  binding  to  a 
Glutathione SepharoseTM or a Ni+2-NTA resins could be that the protein was 
refolding in a way that obstructed the availability of the tags to bind either 
resin.  In  order  to  test  this,  a  Ni+2-NTA  resin  purification  (see  2.4.7)  was 
conducted  with  Rx-NBARC  samples  prior  the  refolding  step.  It  is  not 
necessary  to  refold  a  hexa-histidine  tag  in  order  for  it  to  bind  the  resin 
(Rudolph and Lilie, 1996). 
75
3.2.3 Protein purification before refolding (Ni  +2  -NTA resin)  
The hexa-histidine tag does not have to be refolded in order to perform a 
correct Ni+2-NTA resin purification (see 2.4.7; Rudolph and Lilie, 1996). As no 
positive results were obtained from the previous purification trials (see 3.2.1 
and 3.2.2), a Ni+2-NTA resin purification was performed with Rx-NBARC WT 
and Rx-NBARC K176R purified and solubilized inclusion bodies (see 2.4.10), 
prior to refolding the proteins. The results of this purification are shown in 
Figure 25.
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Figure 25 SDS-PAGE gels with samples of (A) Rx-NBARC WT and (B) Rx-NBARC K176R 
obtained during a Ni+2-NTA resin purification (see 2.4.7). (A)  1. Rx-NBARC WT purified and 
solubilized inclusion bodies,  2. Flow through, 3. Wash one (15 mL wash buffer A),  4. Wash 
two (15 mL wash buffer B),  5. Wash three (15 mL wash buffer C),  6-10. Eluates (200  µL 
elution buffer each). (B) 1. Flow through, 2. Wash one (15 mL wash buffer A), 3. Wash two 
(15 mL wash buffer B),  4.  Wash three (15 mL wash buffer C),  5-6. Eluates (200  µL elution 
buffer each).
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Samples  of  Rx-NBARC  WT and  Rx-NBARC  K176R,  before  refolding, 
were subject to a Ni+2-NTA purification (see 2.4.10). Eluates were not clean, 
as  shown  on  the  SDS-PAGE  gels  in  Figure  25  (A 6-7  and  B 5-6). 
Nevertheless, both wild type and K176R mutant were cleaner than samples 
obtained from inclusion bodies purification (see 2.4.10).
After  the  Ni+2-NTA  purification,  eluates  were  refolded  (see  2.4.12), 
dialysed (see 2.4.13) and concentrated with PEG 8000 (see 2.4.14). Protein 
concentration of Rx-NBARC WT and Rx-NBARC K176R was calculated by 
Bradford  assay  (see  2.4.6).  Both  samples  were  made  to  the  same 
concentration  and  their  nucleotide  phosphatase  activities  were  compared 
(Figure 26). Aliquots were examined by SDS-PAGE gel (see 2.4.4; Figure 27).
 
WT K176R 
Figure  26 Nucleotide phosphatase assay performed on Rx-NBARC WT and Rx-NBARC 
K176R samples having been purified with Ni+2-NTA resin (see 2.4.7), refolded (see 2.4.12), 
dialysed (see 2.4.13) and made the same concentration. Data was read with a TLC scanner.  
Red areas correspond to ADP, green to adenosine.
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Figure  27 SDS-PAGE gel  (see  2.4.4)  with  samples  of  Rx-NBARC WT and Rx-NBARC 
K176R that have been purified with a Ni+2-NTA resin (see 2.4.7), refolded (see 2.4.12) and 
dialysed (see 2.4.13). 
Data  on  Figure  26  shows  that  Rx-NBARC  WT has  a  higher  specific 
activity (see 2.5.5) for ADP as substrate in a nucleotide phosphatase assay 
than  Rx-NBARC  K176R.  These  are  preliminary  nucleotide  phosphatase 
assays, as the samples are not clean. When aliquots of these samples are 
run on a SDS-PAGE gel (see 2.4.4, Figure 27), four visible bands appear and 
may correspond to four proteins. These four bands were cut and the SDS-
PAGE gel  slices  corresponding  to  these  bands  were  analysed  by  MALDI 
(Matrix-assisted  laser  desorption/ionization)  mass  spectrometry  to  identify 
them. The results obtained by these means were compared to the Mascot 
Search protein database. This confirmed a statistically significant homology of 
the protein present in band 1 with a GST tagged protein from a glutathione S-
transferase cloning vector. As this band is of the correct size of Rx-NBARC, 
which has a GST tag, it is predicted to be Rx-NBARC. Band 2 corresponds to 
elongation factor Tu from E. coli, of about 44 kDa, which matches the size of 
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the  second  band  on  the  SDS-PAGE gel.  Band  3  showed  homology  with 
different keratin 10 isoforms and with β-lactamases, but as these proteins do 
not match the molecular weight of band 3 in Figure 27, this protein remains 
unidentified. Various 30S ribosomal subunit proteins showed homology with 
the sequence from the protein present in band 4 and they all matched with its 
size. 
3.2.4 Exchange chromatography after a Ni  +2  -NTA purification and refolding:  
Samples of Rx-NBARC WT and Rx-NBARC K176R obtained after a Ni+2-
NTA resin purification, refolding, dialysing and concentrating with PEG 8000 
(see 3.2.3) were subject to anion exchange chromatography to polish the Rx 
proteins of contamination (Figure 27). This was unsuccessful, despite multiple 
attempts: no Rx-NBARC WT or Rx-NBARC K176R proteins were recovered. 
The  samples  might  have  diluted  too  much  during  the  process  of  anion 
exchange chromatography. A new experimental protocol was tested to obtain 
bigger amounts of clean Rx, as anion exchange proved to dilute too much the 
samples. 
3.2.5 Electroelution:
As the Ni+2-NTA purification was not giving sufficient purified material for 
in  depth analysis,  and in order  to  obtain  cleaner  Rx-NBARC WT and Rx-
NBARC  K176R  samples,  electroelution  was  tested  as  an  alternative 
approach. When electroeluting proteins, a sample containing the protein of 
interest is run on a SDS-PAGE gel which is big enough to clearly separate 
different  size  proteins  into  distinct  bands.  The  area  corresponding  to  the 
correct size band is cut from the gel and introduced in a dialysis bag. The bag 
is placed in a tank with a running current. This will cause the protein to elute 
from the gel slice and into the buffer in the dialysis bag. Denatured protein is  
accumulated in the buffer inside the dialysis bag (electroeluate) and can be 
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used  for  refolding  experiments.  The  samples  of  Rx-NBARC WT and  Rx-
NBARC  K176R  used  for  electroelution  (see  2.4.15)  were  purified  and 
solubilized  inclusion  bodies  (see  2.4.10).  After  electroelution  (see  2.4.15), 
electroeluates were subjected to refolding (see 2.4.12), dialysis (see 2.4.13) 
and concentration with PEG 8000 (see 2.4.14). 
Samples of Rx-NBARC WT and Rx-NBARC K176R from purified inclusion 
bodies (see 2.4.10) were run on 20 cm long SDS-PAGE gels (see 2.4.4). The 
first gel was stained with Coomassie blue (Figure 28) in order to determine 
the position of the correct size band (75 kDa) on the gel. Bands corresponding 
to this size from subsequent gels were cut and used for electroelution (see 
2.4.15).  The presence of  electroeluted protein  was checked with  an SDS-
PAGE gel (see 2.4.4; Figure 29).
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Rx-NBARC 
Figure 28 20 cm long SDS-PAGE gel with a sample of purified inclusion bodies from Rx-
NBARC WT (75 kDa). The gel was stained with Coomassie blue in order to locate the position 
of the correct size (75 kDa) band in relation with the prestained protein ladder used.
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Rx-NBARC 
DnaK? 
Figure 29 SDS-PAGE gel with a sample of electroeluted Rx-NBARC K176R.
Two bands appear in the SDS-PAGE run with an electroeluate sample of 
Rx-NBARC K176R (Figure 29). The top one is Rx-NBARC K176R. The lower 
band is conceivably DnaK. DnaK is an Hsp70-family member chaperone in E. 
coli of 70 kDa. It was purified with R1 and PSiP in Fenyk et al., 2012, but this 
awaits further testing.
After  proving  the  presence  of  a  protein  of  the  correct  size  in  the 
electroeluted sample (Figure 29),  the whole electroeluate (see 2.4.15) was 
refolded (see 2.4.12), dialysed (see 2.4.13) and concentrated with PEG 8000 
(see 2.4.14). The presence of protein at this stage was tested by Bradford 
(see 2.4.6) and nucleotide phosphatase assays (see 2.5.2). 
After  a  series  of  electroelutions  (see  2.4.15),  refolding  (see  2.4.12), 
dialysis  (see 2.4.13)  and concentrations (see 2.4.14),  four  samples of  Rx-
NBARC WT and two samples of Rx-NBARC K176R were obtained. Protein 
concentrations were established for each sample through a Bradford assay 
(see  2.4.6).  The  same amount  of  protein,  0.43  µg,  was  used  to  test  the 
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nucleotide  phosphatase  activity  of  each  preparation  (see  2.5.2)  and  a 
comparison of their specific activities was calculated (see 2.5.5; Figure 30 for  
Rx-NBARC WT and Figure 31 for Rx-NBARC K176R).
Figure 30 Nucleotide phosphatase specific activity (see 2.5.5) of four different electroeluted 
and refolded Rx-NBARC WT samples. Error bars correspond to the standard error of the 
mean (n=3). 
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Figure 31 Nucleotide phosphatase specific activity (see 2.5.5) of two different electroeluted 
and refolded Rx-NBARC K176R samples. Error bars correspond to the standard error of the 
mean (n=3). 
Differences between each sample’s specific activity (see 2.5.5; Figures 30 
and  31)  could  be  due  to  inconsistent  folding  of  the  protein  during  the 
purification process. Also, it could be stated that the K176R mutant version of 
Rx-NBARC has consistently less nucleotide phosphatase specific activity than 
the wild type, even though it could be possible that both mutant samples are 
incorrectly folded. To state with total certainty that the difference in specific 
activity  is  only  due  to  the  mutation,  circular  dichroism  (CD)  experiments 
should be conducted. CD spectroscopy measures differences in left and right-
handed polarized light. Secondary structure in proteins will create a distinct 
spectrum for its molecule when analysed by CD spectroscopy (Matsuo et al., 
2005). This data can be used to compare the structure of a protein under 
different conditions, to study the effect of different mutations in the proteins 
structure, to compare different proteins or as a first step before resolving a 
tertiary structure (Lobley  et al., 2002). It would be possible to identify if Rx-
NBARC WT and Rx-NBARC K176R samples are correctly folded, if there are 
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differences between each sample or if it is the K176R mutation in Rx-NBARC 
that causes the decrease in specific activity in this protein. 
Samples Rx-NBARC WT 4 and Rx-NBARC K176R 2 present the higher 
specific  activity  (see  2.5.5)  and,  were  chosen  for  further  biochemistry 
experiments, unless otherwise specified. 
3.2.6 Biochemistry of Rx-NBARC:
Most R proteins have a variable N-terminus, consisting of a coiled-coil 
(CC) domain or  a TIR (homologue of the  Drosophila Toll  and mammalian 
interleukin-1 receptors) domain. The conserved central domain is predicted to 
bind nucleotides (NBARC) and there is a variable leucine-rich region (LRR) at 
the C-terminus (Boller and He, 2009 and Zipfel, 2009). The NBARC domain 
has a P-loop structure (van Ooijen et al., 2008). P-loop NTPases are the most 
common  NTP-binding  proteins  in  the  proteome.  They  are  found  in  all 
organisms  and  they  form the  fifth  largest  family  with  the  human  genome 
(Gueguen-Chaigon et al., 2007). 
The current theory in the literature postulates that R proteins are strict 
ATPases with an “on-off” activation model (Takken et al., 2006 and Tameling 
et al., 2002). In this model, the inactive or “off” state corresponds to that of the 
NBARC  domain  of  the  protein  interacting  with  the  LRR  and  C-terminus 
domains and an ADP molecule (Tameling et al., 2002). It is not known what 
triggers nucleotide exchange in R proteins, but exchange of ADP for an ATP 
causes a conformational change in the protein and its consequent activation,  
entering the “on” state. It is the hydrolysis of the ATP molecule that returns an 
R protein  to  its  inactive,  autoinhibited  state.  Recent  results  (Fenyk  et al., 
2012)  show  that  R1,  an  orphan  R  protein  from  rice,  is  a  nucleotide 
phosphatase with  a substrate preference of AMP>ADP>ATP and so, strict 
ATPase is not its main activity. Unpublished data on R1, PSiP, and I-2 has 
shown that R proteins bind and damage DNA. Different studies (Choi  et al., 
2001 and Wang et al., 2010) show there is relation between R protein genes 
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and DNA binding and damaging. Choi et al., 2001 demonstrated the similarity 
in gene expression induced by DNA-damaging agents and by R proteins in a 
study performed on pea endocarp tissue. Wang et al., 2010 have identified 
DNA repairing enzymes (BRCA2 and RAD51) in screens for immune related 
genes. DNA damage could be used as a signal to trigger plant innate immune 
responses as various studies state that the localization of R proteins in either  
the  nucleus  or  the  cytoplasm  is  key  for  their  correct  immune  signalizing 
(Burch-Smith  et al., 2007, Cheng  et al., 2009, Wirthmueller  et al., 2007 and 
Zhu et al., 2010). Moreover, Rx has been located in the nucleus as well as the 
cytoplasm (Slootweg  et al., 2010) and it has been demonstrated that its N-
terminus is related with  a member of the RanGAP2 family involved in the 
trafficking through nuclear pores (Tameling et al., 2010).
The data presented here represents the initial stage of a larger project to 
be  continued further.  Rx-NBARC has been used to  test  its  strict  ATPase, 
nucleotide phosphatase and DNA nicking activities. Toward this end, a series 
of strict ATPase, nucleotide phosphatase and DNA nicking experiments have 
been conducted. Rx-NBARC WT and Rx-NBARC K176R samples were used, 
after being electroeluted and refolded (see 3.2.5). 
3.2.6.1 Confirmation of the activity of Rx-NBARC: strict ATPase or nucleotide  
phosphatase?
As previous results indicate a break from the main line of thought of Rx 
being a strict ATPase (Fenyk et al., 2012), purified Rx-NBARC samples were 
tested for both strict ATPase and nucleotide phosphatase activity. 
Strict ATPase and nucleotide phosphatase assays were run in precoated 
TLC plates (see 2.5.3 and 2.5.4). The results were read on a TLC scanner 
where absorbance at 256 nm was measured for each sample. The position of 
ATP,  ADP,  AMP  and  adenosine  (Ado)  molecules  on  TLC  plates  was 
examined.  Once  this  was  established,  further  ATPase  and  nucleotide 
phosphatase activity tests could be conducted and properly analysed. 
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Where should ATP, ADP, AMP and Ado appear?
When  performing  nucleotide  phosphatase  and  strict  ATPase  assays, 
ATP, ADP, AMP and Ado molecules are separately chromatographed. The 
position  to  which  these  molecules  migrate  when  the  reaction  is  run  with 
nucleotide phosphatase assay developing buffer  was known (Fenyk  et al., 
2012),  but this was not established when using ATPase assay developing 
buffer. Therefore, [3H]-ATP, [3H]-ADP, [3H]-AMP, and [3H]-Ado derived from a 
nucleotide phosphatase assay with R1 (Fenyk et al., 2012) were spotted on a 
TLC plate. ATPase developing buffer was used to separate the molecules as 
described in  2.5.3  and the  plate  was  read on a TLC scanner  at  256 nm 
(Figure 32).
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Figure 32 Position where ATP, ADP, AMP and Ado molecules stop on a precoated TLC plate 
when developed with strict ATPase developing buffer (see 2.5.3). ATP appeared on a window 
between 20 and 35 mm, ADP between 50 and 70 mm, AMP between 55 and 70 mm and Ado 
between 65 and 85 mm. 
Figure 32 shows that, with this ATPase assay developing buffer, ADP and 
AMP are not  separated.  This  is  not  significant  for  this  experiment  as it  is 
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possible to separate ATP, ADP/AMP, and Ado this is sufficient to discriminate 
between a strict ATPase and nucleotide phosphatase activity. A second peak 
is visible when running [3H]-ATP (Figure 32, ATP, red peak).  This peak is 
evident on mixing ATP is mixed and reaction buffer (see 2.5.1) and could be 
due to  the interaction of  ATP with  metal,  which would cause a change in  
ATP’s charge and, therefore, its migratory properties. No further tests were 
conducted to confirm this hypothesis, as it has no implications for assays to 
be performed. Both ATPase and nucleotide phosphatase activity experiments 
were conducted with Rx-NBARC WT and Rx-NBARC K176R samples. 
Is Rx-NBARC a strict ATPase or a nucleotide phosphatase?
Once ATP, ADP/AMP and Ado peaks on TLC plates were identified, strict 
ATPase  (see  2.5.1)  and  nucleotide  phosphatase  (see  2.5.2)  assays  were 
conducted  and  analysed  with  Rx-NBARC  samples.  Apyrase  from  potato 
(Solanum  tuberosum),  an  ATPase  with  ≥  50  % of  base  activity  ADPase 
(Handa and Guidotti, 1996) was used as a positive control for ATPase activity.  
Both Rx-NBARC WT and apyrase were used to test their strict ATPase and 
nucleotide phosphatase activity.  The production of Ado and ADP/AMP was 
compared for both enzymes (Figure 33).
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Figure 33 Specific strict ATPase and nucleotide phosphatase activity (see 2.5.5) of (A) Rx-
NBARC WT (B) and apyrase. Strict ATPase assays (see 2.5.1) were conducted with both 
samples under the same conditions and absorbance at 256 nm was measured for both Ado 
and ADP/AMP. Error bars correspond to the standard error of the mean (n=3).
ADP/AMP and Ado were measured after an assay (see 2.5.1 and 2.5.3) 
conducted separately with Rx-NBARC WT (Figure 33, A) and apyrase (Figure 
33,  B). This data shows that Rx-NBARC WT cannot be considered a strict 
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ATPase, but a nucleotide phosphatase. The production of Ado by Rx-NBARC 
WT is significantly higher compared to the production of ADP/AMP. When 
compared to apyrase’s activity,  it  is demonstrated that these two enzymes 
have different activities. In Figure 33,  B, apyrase shows to produce Ado as 
well  as ADP/AMP. This could be explained with a low substrate affinity for 
AMP and higher substrate affinity for ATP and ADP. That would be why there 
is Ado production, while most ADP/AMP molecules are not modified. 
From Figure 33, it is clear that apyrase also produced Ado. This enzyme 
could have a lower affinity for AMP than for ADP and ATP and, therefore, 
produces Ado while there is still ADP/AMP 
Having established that Rx-NBARC is a nucleotide phosphatase and not 
a strict ATPase, it is now necessary to check the protein’s affinity for different 
substrates and the role of the P-loop in this activity. 
3.2.6.2 Rx-NBARC as a nucleotide phosphatase:
As  seen  from  the  previous  section  (3.2.6.1),  Rx-NBARC  WT  is  a 
nucleotide phosphatase and not a strict ATPase. This is in contraposition to 
the current theory that plant R proteins are strict ATPases. In order to have a 
better knowledge about the biochemistry of Rx, substrate affinity was tested. 
Nucleotide  phosphatases  may  have  different  affinity  towards  different 
nucleotides (Fenyk  et al., 2012). P-loop mutants in other resistance proteins 
have shown to cause a loss-of-function phenotype (Takken et al., 2006) due 
to a much lower substrate affinity for the substrate in comparison with the wild  
type. A mutant version of Rx-NBARC that corresponded with this type of P-
loop mutation (Rx-NBARC K176R) was used to compare its activity to that of 
the wild type (Rx-NBARC WT).
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Substrate affinity:
Knowing the affinity of Rx for different nucleotides as substrates will help 
future work towards the understanding of how resistance proteins, as a whole,  
trigger  an  innate  immune  response  in  plants.  Nucleotide  phosphatase 
experiments  (see  2.5.2)  using  ATP,  ADP  and  AMP  as  substrates  were 
conducted using 16 ng of Rx-NBARC WT in each reaction. Nucleotides were 
added to a final concentration of 5  µM and reactions were performed under 
the same conditions (Figure 34).
Figure 34 Nucleotide phosphatase specific activity (see 2.5.5) of Rx-NBARC WT using AMP, 
ADP and ATP as substrates. Error bars correspond to the standard error of the mean (n=3).
Figure 34 shows a difference in  affinity of  the nucleotide phosphatase 
activity  for  ATP,  ADP and  AMP as  substrates.  This  affinity  is  as  follows: 
ATP<ADP<AMP. These same results are similar to those reported in Fenyk 
et al., 2012 for R1. 
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Differences in  specific  activity  between Rx-NBARC WT and Rx-NBARC  
K176R:
Rx-NBARC K176R presents a mutation in the kinase 1A or P-loop motif of  
the protein. Equivalent mutations in other resistance proteins have shown to 
cause  a  loss-of-function  phenotype  (Takken  et al.,  2006).  P-loop  mutants 
have  a  lower  substrate  affinity  than  that  of  the  wild  type  R  protein.  A 
nucleotide  phosphatase  assay  (see  2.5.2)  was  performed  with  both  Rx-
NBARC WT and Rx-NBARC K176R (Figure 35).
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Figure 35 Comparison of nucleotide phosphatase specific activity (see 2.5.5) in Rx-NBARC 
WT and Rx-NBARC K176R. Error bars correspond to the standard error of the mean (n=3). 
Figure 35 was analysed with data from nucleotide phosphatase assays 
(see  2.5.2)  with  Rx-NBARC  WT  and  Rx-NBARC  K176R.  The  same 
concentration of substrate (5  µM ADP) and protein (160 ng) was added to 
each of the experiments that were incubated for the same time at the same 
temperature. This figure shows that Rx-NBARC WT has a higher nucleotide 
phosphatase specific activity than Rx-NBARC K176R.
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3.2.6.3 DNA nicking of Rx-NBARC:
Unpublished data from experiments with  R1, PSiP, and I-2 has shown 
that R proteins bind and damage DNA. This could trigger an innate immune 
resistance  response  in  plants  (Choi  et al.,  2001  and  Wang  et al.,  2010). 
Damaging DNA would be used as a way to signal  pathogen infection and 
trigger a response. In order to establish if Rx nicks DNA, viral dsDNA was 
used in DNA nicking experiments (see 2.5.6) with all Rx-NBARC WT and Rx-
NBARC K176R samples (Figure 36, Figure 37).
Supercoiled DNA 
Open circle DNA 
Unidentified circular form DNA 
Linear DNA 
Large DNA-protein aggregates? 
Figure 36 Agarose gel showing the results from a viral dsDNA nicking (see 2.5.6) experiment 
with Rx-NBARC WT and Rx-NBARC K176R samples. 1, 0.5 µg viral dsDNA; 2, 0.5 µg viral 
dsDNA with STOP buffer;  3, 0.5 µg viral dsDNA and 1 µg BSA with STOP buffer; 4, 0.5 µg 
viral dsDNA and 0.43 ng Rx-NBARC WT 1 with STOP buffer; 5, 0.5 µg viral dsDNA and 0.43 
ng Rx-NBARC WT 2 with STOP buffer; 6, 0.5 µg viral dsDNA and 0.43 ng Rx-NBARC WT 3 
with STOP buffer; 7, 0.5 µg viral dsDNA and 0.43 ng Rx-NBARC WT 4 with STOP buffer; 8, 
0.5 µg viral dsDNA and 0.43 ng Rx-NBARC K176R 1 with STOP buffer; 9, 0.5 µg viral dsDNA 
and 0.43 ng Rx-NBARC K176R 2 with STOP buffer; 10, 0.5 µg viral dsDNA and 1 µg DNAase 
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I with STOP buffer.
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Figure 37 Percentage of supercoiled DNA compared to linear DNA on an agarose gel (Figure  
35).Viral dsDNA was used on a DNA nicking assay (see 2.5.6) testing the nicking activity in  
four  samples  of  Rx-NBARC WT and two  samples  of  Rx-NBARC K176R.  1,  0.5  µg viral 
dsDNA;  2, 0.5  µg viral dsDNA with STOP buffer;  3, 0.5  µg viral dsDNA and 1 µg BSA with 
STOP buffer; 4, 0.5 µg viral dsDNA and 0.43 ng Rx-NBARC WT 1 with STOP buffer; 5, 0.5 µg 
viral dsDNA and 0.43 ng Rx-NBARC WT 2 with STOP buffer; 6, 0.5 µg viral dsDNA and 0.43 
ng Rx-NBARC WT 3 with STOP buffer; 7, 0.5 µg viral dsDNA and 0.43 ng Rx-NBARC WT 4 
with STOP buffer; 8, 0.5 µg viral dsDNA and 0.43 ng Rx-NBARC K176R 1 with STOP buffer; 
9,  0.5  µg  viral  dsDNA  and  0.43  ng  Rx-NBARC K176R 2  with  STOP buffer.  Error  bars 
correspond to the standard error of the mean (n=3).
Data in Figures 36 and 37 demonstrates that Rx-NBARC nicks and, likely 
binds DNA. It is possible to compare the nucleotide phosphatase and DNA 
nicking specific activities of each sample (Figures 30 and 37 respectively).  
This comparison demonstrates that the most active samples in a nucleotide 
phosphatase assay (see 2.5.2) are the most active on a DNA nicking assay 
(see 2.5.6) too. It  is also noteworthy that both Rx-NBARC K176R samples 
have low nucleotide phosphatase and DNA nicking activities (Figures 31 and 
37, respectively), comparable to that of sample Rx-NBARC WT 1 (Figure 30 
and 37). This can be due to the mutation itself or to missfolding problems.
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DNA binding of Rx-NBARC:
Data presented in the previous section shows that Rx-NBARC nicks DNA, 
but does it bind to it too? No specific experiment was conducted in order to 
clarify if Rx-NBARC binds DNA, but it is possible to hypothesize from what 
Figure 37 shows. On lanes 5, 6 and 7, not all DNA has entered the gel. It is 
plausible to hypothesize that this is due to Rx-NBARC interacting with DNA, 
forming aggregates too big to enter a 1 % agarose gel. The samples on these 
lanes are also the most active ones,  both nicking DNA and as nucleotide 
phosphatases  with  ADP as  substrate  (Figures  37  and  30).  Having  this  in 
mind, it is conceivable to hypothesize that Rx-NBARC binds DNA. This idea 
would be in consonance with unpublished data on other R proteins. 
Expressing soluble, active R proteins has proved to be very challenging. 
Transformed cells might experience toxicity due with residual expression of 
these  proteins,  as  they  are  nucleotide  phosphotases.  In  this  project  it  is 
demonstrated  that  both  R1-NBARC  (3.1.4)  and  Rx-NBARC  (3.2.1)  are 
accumulated in inclusion bodies, which can be purified. Rx-NBARC samples 
could be polished of impurities and refolded (3.2.1) to form soluble,  active 
protein  used  in  a  series  of  biochemical  assays  (3.2.5  and  3.2.6).  Data 
obtained from these experiments demonstrate that Rx-NBARC is not a strict  
ATPase,  but  a  nucleotide  phosphatase  (3.2.6.1).  This  difference  from the 
current theory of R proteins being strict ATPases has been previously seen in 
experiments conducted on R1 (Fenyk et al., 2012). It can also be stated that 
Rx-NBARC nicks DNA (3.2.6.3). This is in supported with data published in 
Slootweg  et al.,  2010  and  Tameling  et al.,  2010.  These  two  projects 
demonstrate  that  Rx’s  immune  signalling  activity  is  related  to  its 
nucleocytoplasmic distribution and that Rx’s N-terminus domain interacts with 
a member of RanGAP2 family involved in trafficking through the nuclear pore. 
In conjunction, these results can be used in further R proteins analysis. 
Efforts  should  be  focused  towards  the  obtaining  of  clean  samples  of  R 
proteins  that  could  be  used  in  crystallography  experiments.  Solving  a  R 
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protein (or its active domain) structure would be of high importance for the full  
understanding and knowledge of plant immunity.
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4. Conclusion and Future work
4.1 R protein expression and purification
Expressing and purifying R proteins showed to be very challenging.  R 
proteins hydrolyse phosphoester  bonds in nucleotides (Fenyk  et al.,  2012, 
Tameling et al., 2006). Residual expression of these proteins, if active, could 
cause cell death. This might be the explanation as to why obtaining a soluble 
R  protein  through  bacterial  culture  is  so  difficult  and  why  the  use  of 
chaperones did not help in obtaining better results. Nevertheless, Ueda et al., 
2006  succeeded  in  the  expression  and  purification  of  active  N  protein 
constructs from E. coli cultures. In a similar way, Fenyk et al., 2012 expressed 
and  purified  R1,  Rpm1  and  PSiP  active  domains  from  bacteria  cultures.  
Expression of R1 and PSiP constructs used in this study yielded high protein 
concentrations. On the other hand, the expression of Rpm1 did not produce a 
high amount of protein. This contrast might be due to the different specific 
activities of  R1,  PSiP,  and Rpm1.  R1 and PSiP showed a low nucleotide 
phosphatase  specific  activity,  while  Rpm1  had  a  higher  nucleotide 
phosphatase specific activity. This explanation might be true for experiments 
conducted on Rx in this project. A possible reason for Rx not expressing as 
soluble protein might be its high nucleotide phosphatase specific activity. 
Bacteria  can  accumulate  toxic  proteins  in  inclusion  bodies.  Various 
proteins have been purified from inclusion bodies and been refolded before 
(Rudolph and Lilie, 1996) resulting in active proteins in solution. Tameling et 
al.,  2002  purified  two  R  proteins,  I-2  and  Mi-1,  from  inclusion  bodies  in 
cultures of E. coli. Posterior refolding in vitro proved to yield active proteins. A 
similar protocol is the one described in this project (see 3.2). In this case, an 
extra purification step was added after  the purification of  inclusion bodies. 
Samples obtained are not suitable for crystallography trials, but can be used 
in biochemistry assays. This methodology, if improved, could be used for R 
proteins purification and may render a clean sample that can be used towards 
a  NB-ARC  crystal  structure.  Solving  a  NB-ARC domain  structure  from  R 
proteins would be key in the progress of an understanding of plant innate 
immunity. 
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4.2 Rx-NBARC biochemistry
4.2.1 Rx NB-ARC domain activity
The currently accepted theory of R protein activation proposes R proteins 
as  strict  ATPases  in  an  “on-off”  switch  activation  model  (Takken  and 
Tameling, 2009). Recent findings by Fenyk et al., 2012 on a group of three R 
proteins differ from this theory. R1 (orphan R protein from rice), PSiP (orphan 
R  protein  from  maize),  and  Rpm1  (R  protein  from  Arabidopsis)  act  as 
nucleotide phosphatases, not strict ATPases. Results with Rx-NBARC proved 
this R protein to be a nucleotide phosphatase. Two possibilities arise. The first  
possible explanation is that different R proteins can have different activities. 
On  the  other  hand,  no  Rx  samples  without  minor  contaminants  were 
produced. Contaminants present in these samples might be responsible for 
the activity assigned to Rx. Nevertheless, experiments conducted on a loss-
of-function P-loop mutant version of Rx (Rx-NBARC K176R) proved to have 
lower  nucleotide  phosphatase  specific  activity,  while  presenting  the  same 
contaminants. Further studies, free of contaminants, of Rx protein should be 
accomplished with further improvement to methodology. 
4.2.2 DNA nicking activity
R proteins have been localized in the cytoplasm and the nucleus of plant 
cells  (Slootweg  et al.,  2010).  For  complete  activation  of  ETI,  various  R 
proteins  need  to  be  localized  in  the  nucleus.  Burch-Smith  et al.,  2007 
demonstrated transport into the nucleus from the cytoplasm was needed for N 
to  properly  activate  an  immune  response.  Wirthmueller  et al.,  2007 
demonstrated this same fact for RPS4, and Zhu  et al., 2010 for SNC1. The 
importance  of  interaction  between  R  proteins  and  nucleocytoplasmic 
transporters is proved in Cheng et al., 2009. Moreover, the gene expression 
induced by R proteins activation is similar to that caused by DNA-damaging 
agents (Choi  et al.,  2001) and Wang  et al.,  2010 identified DNA repairing 
enzymes  that  interact  with  R  proteins.  It  is  clear  from  these  data  that  R 
proteins' function is related to their localization both in the cytoplasm and the 
nucleus.  DNA damage could  be  used  in  the  signalling  process  to  trigger 
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plants innate immunity. 
In this project, Rx-NBARC was used in DNA nicking experiments to prove 
the capability of the protein to damage DNA. However, once a clean sample 
of R protein is obtained, this activity should be confirmed, as mentioned for  
before in 4.2.1. 
4.3 Future work
Data presented here could be used in future projects where R protein 
activity and structure is studied. Experiments should be conducted to confirm 
the correct refolding of the protein. The structure of Rx-NBARC WT and Rx-
NBARC K176R in solution should be compared by circular dichroism. This 
would be key to state that nucleotide phosphatase and DNA nicking activity 
differences shown by wild type and mutant samples are due to the P-loop 
mutation and not to inconsistent folding of the proteins in each solution. 
The  final  target  of  this  future  project  should  be  solving  an  R  protein 
structure. This would be key for the understanding of these proteins’ function 
and their role in plant innate immunity. In order to achieve this, clean samples 
of protein  should be obtained and crystallized.  The problems to  overcome 
here are not only in the crystallization and structure solving processes, but 
also in the expression and purification processes. R proteins are expressed 
and  accumulated  in  inclusion  bodies.  The purification  of  these proteins  is 
extremely  difficult.  To  obtain  a  higher  concentration  of  protein  in  a  clean 
sample  will  be  the  next  step  forward.  A  second  purification  step  after 
electroelution  could  be  an  option  (anion  exchange  chromatography,  for 
example).
Once an NB-ARC domain crystal from a R protein is available, important 
catalytic residues can be proposed as targets for protein modifications that  
may render R proteins with new activation regulation pathways. 
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6. Appendices
6.1. Appendix 1: expression vectors
Construct Insert Vector
R1-NBL2 R1145-237 pCola2-DEST
R1-NBARC2 R1145-521 pCola2-DEST
R1-NBL3 R1145-237 pCola3-DEST
R1-NBARC3 R1145-521 pCola3-DEST
Rx-NBARC WT Rx1-486 pGEX-4T-1
Rx-NBARC K176R RxK176R 1-486 pGEX-4T-1
6.2. Appendix 2: primers
Primer Sequence  of 
nucleotides
Gene
MJC188 GTA  AAA  CGA  CGG 
CCA G
M13 forward sequencing 
primer
MJC522 GGC  CTC  GAG  GGA 
CAG  ACG  TTG  CTG 
ACC
LOC_Os02g25900
MJC535 GGC  ACC  ACT  TTG 
TAC  AAG  AAA  GCT 
GGG  TCG  GAC  AGA 
CGT TGC TGA CC
LOC_Os02g25900
MJC540 Ggc  ACA  AGT  TTG 
TAC  AAA  AAA  GCA 
GGC  TCG  GCA  GGC 
TCA CTG CAC AGC G
LOC_Os02g25900
MJC541 GGC  ACC  ACT  TTG 
TAC  AAG  AAA  GCT 
GGG  TCG  TCC  ATT 
TTA TCC ACG CG
LOC_Os02g25900
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6.3. Appendix 3: chaperone vectors
Chaperones Plasmid Reference
Lac Iq, Gro ESL pBB528, pBB541 De  Marco  et  al.,  2007 
and  Tomoyasu  et al., 
2001
DnaK, DnaJ, Gro ESL low 
concentration, GrpE, ClpB
pBB550, pBB540 De  Marco  et  al.,  2007 
and  Tomoyasu  et al., 
2001
DnaK, DnaJ, GrpE, ClpB pBB535, pBB540 De  Marco  et  al.,  2007 
and  Tomoyasu  et al., 
2001
DnaK, DnaJ, GrpE pBB535, pBB530 De  Marco  et  al.,  2007 
and  Tomoyasu  et al., 
2001
DnaK, DnaJ, Gro ESL high 
concentration, GrpE, ClpB
pBB542, pBB540 De  Marco  et  al.,  2007 
and  Tomoyasu  et al., 
2001
DnaK, DnaJ. GroESL high 
concentration
pBB542 De Marco et al., 2007
DnaK, Dna J, Gro ESL low 
concentration
pBB550 De Marco et al., 2007
Ibp AB pBB572 De Marco et al., 2007
6.4. Appendix 4: chaperone strains
Name Construct Chaperones
R1-NB L2 I R1-NB L2 Lac Iq, Gro ESL
R1-NB L2 II R1-NB L2 DnaK,  DnaJ,  Gro  ESL 
low concentration, GrpE, 
ClpB
R1-NB L2 III R1-NB L2 DnaK, DnaJ, GrpE, ClpB
R1-NB L2 IV R1-NB L2 DnaK, DnaJ, GrpE
11
R1-NB L2 V R1-NB L2 DnaK,  DnaJ,  Gro  ESL 
high  concentration, 
GrpE, ClpB
R1-NB L2 VI R1-NB L2 DnaK,  DnaJ.  GroESL 
high oncentration
R1-NB L2 VII R1-NB L2 DnaK,  Dna  J,  Gro  ESL 
low concentration
R1-NB L2 VIII R1-NB L2 Ibp AB
R1-NB L3 I R1-NB L3 Lac Iq, Gro ESL
R1-NB L3 II R1-NB L3 DnaK,  DnaJ,  Gro  ESL 
low concentration, GrpE, 
ClpB
R1-NB L3 III R1-NB L3 DnaK, DnaJ, GrpE, ClpB
R1-NB L3 IV R1-NB L3 DnaK, DnaJ, GrpE
R1-NB L3 V R1-NB L3 DnaK,  DnaJ,  Gro  ESL 
high  concentration, 
GrpE, ClpB
R1-NB L3 VI R1-NB L3 DnaK,  DnaJ.  GroESL 
high oncentration
R1-NB L3 VII R1-NB L3 DnaK,  Dna  J,  Gro  ESL 
low concentration
R1-NB L3 VIII R1-NB L3 Ibp AB
R1-NBARC2 I R1-NBARC2 Lac Iq, Gro ESL
R1-NBARC2 II R1-NBARC2 DnaK,  DnaJ,  Gro  ESL 
low concentration, GrpE, 
ClpB
R1-NBARC2 III R1-NBARC2 DnaK, DnaJ, GrpE, ClpB
R1-NBARC2 IV R1-NBARC2 DnaK, DnaJ, GrpE
R1-NBARC2 V R1-NBARC2 DnaK,  DnaJ,  Gro  ESL 
high  concentration, 
GrpE, ClpB
R1-NBARC2 VI R1-NBARC2 DnaK,  DnaJ.  GroESL 
high oncentration
R1-NBARC2 VII R1-NBARC2 DnaK,  Dna  J,  Gro  ESL 
low concentration
R1-NBARC2 VIII R1-NBARC2 Ibp AB
R1-NBARC3 I R1-NBARC3 Lac Iq, Gro ESL
R1-NBARC3 II R1-NBARC3 DnaK,  DnaJ,  Gro  ESL 
low concentration, GrpE, 
ClpB
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R1-NBARC3 III R1-NBARC3 DnaK, DnaJ, GrpE, ClpB
R1-NBARC3 IV R1-NBARC3 DnaK, DnaJ, GrpE
R1-NBARC3 V R1-NBARC3 DnaK,  DnaJ,  Gro  ESL 
high  concentration, 
GrpE, ClpB
R1-NBARC3 VI R1-NBARC3 DnaK,  DnaJ.  GroESL 
high oncentration
R1-NBARC3 VII R1-NBARC3 DnaK,  Dna  J,  Gro  ESL 
low concentration
R1-NBARC3 VIII R1-NBARC3 Ibp AB
6.5. Appendix 5: refolding buffers
 50 
mM 
MES, 
pH 6.0 
50 
mM 
Tris-
HCl, 
pH 8.5 
9.6 
mM 
NaCl 
240 
mM 
NaCl 
0.4 
mM 
KCl 
10 
mM 
KCl 
2mM 
MgCl2 
2 mM 
CaCl2 
0.75 
M 
Guani
dine-
HCl 
0.5 M 
argini
ne 
0.4 M 
sucro
se 
1 mM 
EDTA 
0.05% 
PEG 
3500 
0.5% 
Triton 
X-100 
1mM 
DTT 
1 mM 
GSH 
0.1 
mM 
GSSH 
Buffer 
1 
X  X  X  X X X     X X   
Buffer 
2 
X  X  X  X X  X   X   X X 
Buffer 
3 
X  X  X    X  X X X X X   
Buffer 
4 
X   X  X X X  X    X  X X 
Buffer 
5 
X   X  X   X  X X   X   
Buffer 
6 
X   X  X    X X X X X  X X 
Buffer 
7 
X   X  X X X X    X  X   
Buffer 
8 
 X X  X  X X   X  X X  X X 
Buffer 
9 
 X X  X    X X   X  X   
Buffer 
10 
 X X  X  X X X X X     X X 
Buffer 
11 
 X X  X       X  X X   
Buffer 
12 
 X  X X       X X   X X 
Buffer 
13 
 X  X X    X X  X  X X   
Buffer 
14 
 X  X  X X X X X X  X X  X X 
Buffer 
15 
 X  X  X X X   X    X   
11
11
